Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	1431060	1431060	T	C	exonic	ATAD3B	.	nonsynonymous SNV	ATAD3B:NM_001317238:exon14:c.T1672C:p.Y558H,ATAD3B:NM_031921:exon16:c.T1810C:p.Y604H	1.92E-13	0.056353554	0.943646446	.	0.08529	0.12376	2.166192036	98.0301958	6153.92777	16.40046	0.602	0.056	T	0.0	0.026	B	0.0	0.013	B	0.371	0.044	U	1	0.090	N	-0.69	0.019	N	-3.43	0.944	D	-0.05	0.078	N	0.072	0.097	-0.401	0.720	T	0.539	0.830	D	.	.	.	-1.923	0.009	0.001	0.220	0.009	0.006	0.026	N	c	-1.783	-1.863	0.002	0.089	0.707	0.730	0	-2.41	0.061	-1.313	0.028	-1.859	0.006	0.000	0.063	0.000	0.016	2.734	0.049	.	.	.	0.5	149	232	chr1	1431060	chr1:1431060	T	C	149	PASS	AN=2;DP=232	GT	0/1
chr1	1643940	1643940	-	T	intronic	CDK11A;CDK11B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	201	chr1	1643940	chr1:1643940	G	GT	84	PASS	AN=2;DP=201	GT	0/1
chr1	1688824	1688824	A	-	intronic	NADK	.	.	.	0.00126769	0.990233969	0.008498342	.	0.15314	0.1864	-0.111973265	45.35857514	176.4511	2.88899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	92	chr1	1688823	chr1:1688823	TA	T	79	PASS	AN=2;DP=92	GT	0/1
chr1	8424165	8424165	T	G	exonic	RERE	.	nonsynonymous SNV	RERE:NM_001042682:exon5:c.A29C:p.D10A,RERE:NM_001042681:exon15:c.A1691C:p.D564A,RERE:NM_012102:exon16:c.A1691C:p.D564A	0.999995655	4.34E-06	1.54E-16	DISEASE: Note=A chromosomal aberration involving RERE is found in the neuroblastoma cell line NGP. Translocation t(1;15)(p36.2;q24).; 	0.87038	0.13942	-2.629516077	0.784383109	607.52718	4.98583	0.009	0.682	D	0.999	0.764	D	0.994	0.807	D	.	.	.	1	0.810	D	1.15	0.294	L	3.46	0.053	T	-2.91	0.630	D	0.83	0.818	-0.908	0.471	T	0.027	0.114	T	0.029	0.513	D	4.919	0.661	25.0	0.981	0.381	0.993	0.938	D	c	0.451	0.509	1.000	0.747	0.719	0.830	0	5.17	0.707	7.448	0.795	1.061	0.807	1.000	0.715	1.000	0.888	14.340	0.660	.	.	.	0.5	197	152	chr1	8424165	chr1:8424165	T	G	197	PASS	AN=2;DP=152	GT	1/0
chr1	11254843	11254843	T	C	intronic	ANGPTL7;MTOR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	50	chr1	11254843	chr1:11254843	T	C	104	PASS	AN=2;DP=50	GT	0/1
chr1	24987302	24987302	-	T	intronic	SRRM1	.	.	.	0.999999022	9.78E-07	2.02E-17	.	0.5312	0.11301	-0.929520514	9.683887709	90.5423	2.04787	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	228	chr1	24987302	chr1:24987302	G	GT	64	PASS	AN=2;DP=228	GT	0/1
chr1	29189597	29189597	C	T	exonic	OPRD1	.	synonymous SNV	OPRD1:NM_000911:exon3:c.C921T:p.G307G	0.109062189	0.776662875	0.114274936	.	0.38858	0.34596	-0.139478553	43.29440906	296.04535	3.67407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	135	chr1	29189597	chr1:29189597	C	T	128	PASS	AN=2;DP=135	GT	0/1
chr1	43888327	43888327	C	-	intronic	SZT2	.	.	.	1.52E-07	0.999999848	4.70E-20	.	.	0.09202	.	.	2151.43823	8.5294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	879	chr1	43888326	chr1:43888326	AC	A	78	PASS	AN=2;DP=879	GT	0/1
chr1	47338888	47338888	C	A	ncRNA_intronic	CYP4Z2P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	146	52	chr1	47338888	chr1:47338888	C	A	146	PASS	AN=2;DP=52	GT	1/1
chr1	62175139	62175139	-	T	intronic	TM2D1	.	.	.	0.042061483	0.929476013	0.028462504	.	0.34406	0.09894	.	.	115.6404	2.33925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	91	chr1	62175139	chr1:62175139	A	AT	88	PASS	AN=2;DP=91	GT	0/1
chr1	84355735	84355748	AGAACTTCAAGGAT	-	intronic	TTLL7	.	.	.	0.268072469	0.731927454	7.64E-08	.	0.20746	0.09426	-0.754958418	13.57631517	77.26727	1.8459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	130	35	chr1	84355734	chr1:84355734	AAGAACTTCAAGGAT	A	130	PASS	AN=2;DP=35	GT	1/1
chr1	110129282	110129282	G	T	intronic	GNAI3	.	.	.	0.038811278	0.954295997	0.006892725	DISEASE: Auriculocondylar syndrome 1 (ARCND1) [MIM:602483]: An autosomal dominant craniofacial malformation syndrome characterized by variable mandibular anomalies, including mild to severe micrognathia, temporomandibular joint ankylosis, cleft palate, and a characteristic ear malformation that consists of separation of the lobule from the external ear, giving the appearance of a question mark (question-mark ear). Other frequently described features include prominent cheeks, cupped and posteriorly rotated ears, preauricular tags, and microstomia. {ECO:0000269|PubMed:22560091}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.6315	0.15588	-0.251530012	35.42108988	23.17555	0.77382	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	198	chr1	110129282	chr1:110129282	G	T	113	PASS	AN=2;DP=198	GT	0/1
chr1	114025434	114025434	-	T	intronic	MAGI3	.	.	.	0.570580157	0.429419836	7.05E-09	.	0.93064	0.10933	-0.925889687	9.754659118	136.27247	2.53739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	274	chr1	114025434	chr1:114025434	C	CT	99	PASS	AN=2;DP=274	GT	0/1
chr1	121103631	121103631	-	T	ncRNA_exonic	SRGAP2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	291	chr1	121103631	chr1:121103631	C	CT	106	PASS	AN=2;DP=291	GT	0/1
chr1	143237559	143237559	C	T	intergenic	LOC102723769;MIR6077	dist=35320;dist=435362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	127	chr1	143237559	chr1:143237559	C	T	109	PASS	AN=2;DP=127	GT	0/1
chr1	143237562	143237562	T	A	intergenic	LOC102723769;MIR6077	dist=35323;dist=435359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	126	chr1	143237562	chr1:143237562	T	A	107	PASS	AN=2;DP=126	GT	0/1
chr1	143239358	143239358	C	T	intergenic	LOC102723769;MIR6077	dist=37119;dist=433563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	213	chr1	143239358	chr1:143239358	C	T	130	PASS	AN=2;DP=213	GT	0/1
chr1	144828556	144828556	G	C	exonic	NBPF8;NBPF9	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	176	chr1	144828556	chr1:144828556	G	C	130	PASS	AN=2;DP=176	GT	0/1
chr1	147091501	147091501	C	-	exonic	BCL9	.	frameshift deletion	BCL9:NM_004326:exon8:c.1540delC:p.P516Lfs*4	0.831846217	0.168152551	1.23E-06	.	0.80794	0.11906	-1.626115313	2.878037273	2074.08236	8.39078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	234	chr1	147091500	chr1:147091500	AC	A	69	PASS	AN=2;DP=234	GT	0/1
chr1	150530506	150530506	G	-	exonic	ADAMTSL4	.	frameshift deletion	ADAMTSL4:NM_019032:exon14:c.2263delG:p.G757Vfs*61,ADAMTSL4:NM_025008:exon14:c.2263delG:p.G757Vfs*61,ADAMTSL4:NM_001288607:exon15:c.2146delG:p.G718Vfs*61,ADAMTSL4:NM_001288608:exon15:c.2332delG:p.G780Vfs*61	7.09E-16	0.34016242	0.65983758	DISEASE: Ectopia lentis 2, isolated, autosomal recessive (ECTOL2) [MIM:225100]: An ocular abnormality characterized by partial or complete displacement of the lens from its space resulting from defective zonule formation. {ECO:0000269|PubMed:19200529}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectopia lentis et pupillae (ECTOLP) [MIM:225200]: An ocular abnormality characterized by displacement of the lenses and the pupils, associated with other ocular anomalies, but without systemic manifestations. The condition is usually bilateral, with the lenses and pupils displaced in opposite directions. Additional signs include enlarged corneal diameter, increased corneal astigmatism, increased anterior chamber depth, thinning and flattening of the iris with loss of crypts, angle malformation caused by enlarged iris processes, persistent pupillary membrane, loss of zonular fibers, tilted disk, and increased axial length. Secondary manifestations include refractive errors, glaucoma, early cataract development, and retinal detachment. Membrane formation on the posterior aspect of the iris has been observed both in histologic sections and on ultrasound biomicroscopy. {ECO:0000269|PubMed:20702823}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10654	0.09865	-0.00377668	53.51497995	1103.99507	6.3513	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	821	chr1	150530505	chr1:150530505	TG	T	99	PASS	AN=2;DP=821	GT	0/1
chr1	153516163	153516163	A	-	UTR3	S100A4	NM_019554:c.*72delT;NM_002961:c.*72delT	.	.	0.004651459	0.444541538	0.550807003	.	0.26207	0.5196	-0.185391282	39.67916962	6.99406	0.26106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	438	chr1	153516162	chr1:153516162	GA	G,GAA	71	PASS	AN=2;DP=438	GT	0/1
chr1	153516163	153516163	-	A	UTR3	S100A4	NM_019554:c.*71_*72insT;NM_002961:c.*71_*72insT	.	.	0.004651459	0.444541538	0.550807003	.	0.26207	0.5196	-0.185391282	39.67916962	6.99406	0.26106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	438	chr1	153516162	chr1:153516162	GA	G,GAA	71	PASS	AN=2;DP=438	GT	0/1
chr1	155307999	155307999	-	T	exonic	ASH1L	.	frameshift insertion	ASH1L:NM_018489:exon27:c.8683dupA:p.T2895Nfs*3	1	1.66E-13	1.32E-34	.	0.35554	.	-1.798985783	2.223401746	588.79734	4.92053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	510	chr1	155307999	chr1:155307999	G	GT	82	PASS	AN=2;DP=510	GT	0/1
chr1	155720557	155720557	T	-	intronic	GON4L	.	.	.	0.999998892	1.11E-06	2.27E-19	.	0.14902	0.08718	-1.357871407	4.535267752	369.16949	4.0602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	315	chr1	155720556	chr1:155720556	CT	C,CTT	98	PASS	AN=2;DP=315	GT	0/1
chr1	155720557	155720557	-	T	intronic	GON4L	.	.	.	0.999998892	1.11E-06	2.27E-19	.	0.14902	0.08718	-1.357871407	4.535267752	369.16949	4.0602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	315	chr1	155720556	chr1:155720556	CT	C,CTT	98	PASS	AN=2;DP=315	GT	0/1
chr1	156436092	156436092	-	A	UTR3	MEF2D	NM_001271629:c.*1344_*1345insT;NM_005920:c.*1344_*1345insT	.	.	0.998547093	0.00145288	2.63E-08	.	0.86578	0.19297	-0.624497208	17.16206653	24.10793	0.7919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	144	chr1	156436092	chr1:156436092	C	CA	68	PASS	AN=2;DP=144	GT	0/1
chr1	159032487	159032487	-	T	exonic	AIM2	.	frameshift insertion	AIM2:NM_001348247:exon5:c.711dupA:p.T238delinsNIEK,AIM2:NM_004833:exon6:c.1026dupA:p.T343delinsNIEK	9.01E-08	0.089843818	0.910156092	.	0.0693	0.09293	0.038710339	56.92380278	212.89479	3.1502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	204	chr1	159032486	chr1:159032486	GT	GTT,G	82	PASS	AN=2;DP=204	GT	0/1
chr1	159032487	159032487	T	-	exonic	AIM2	.	frameshift deletion	AIM2:NM_001348247:exon5:c.712delA:p.T238delinsHREVKRTNSSQLV,AIM2:NM_004833:exon6:c.1027delA:p.T343delinsHREVKRTNSSQLV	9.01E-08	0.089843818	0.910156092	.	0.0693	0.09293	0.038710339	56.92380278	212.89479	3.1502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	204	chr1	159032486	chr1:159032486	GT	GTT,G	82	PASS	AN=2;DP=204	GT	0/1
chr1	161580116	161580116	G	T	intergenic	HSPA7;FCGR3B	dist=1775;dist=12872	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	198	chr1	161580116	chr1:161580116	G	T	79	PASS	AN=2;DP=198	GT	0/1
chr1	162773396	162773396	G	A	intronic	HSD17B7	.	.	.	0.001754508	0.896172411	0.102073081	.	.	.	0.016664174	55.21939137	643.08042	5.09426	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	91	chr1	162773396	chr1:162773396	G	A	71	PASS	AN=2;DP=91	GT	0/1
chr1	165721440	165721440	-	A	intronic	TMCO1	.	.	.	9.55E-07	0.530626517	0.469372527	.	0.21693	0.11262	0.057118534	57.99716914	266.50685	3.50211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	289	chr1	165721440	chr1:165721440	T	TA	91	PASS	AN=2;DP=289	GT	0/1
chr1	167893778	167893778	-	A	intronic	MPC2	.	.	.	0.449429467	0.522427122	0.028143411	.	0.22019	0.09609	0.501689326	79.7888653	143.21224	2.60927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	305	chr1	167893778	chr1:167893778	G	GA	92	PASS	AN=2;DP=305	GT	0/1
chr1	168549282	168549282	-	T	intronic	XCL1	.	.	.	0.088160228	0.763202188	0.148637583	.	0.0931	0.20536	0.725794416	85.98136353	269.25512	3.52005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	342	chr1	168549282	chr1:168549282	G	GT	87	PASS	AN=2;DP=342	GT	0/1
chr1	200375406	200375406	-	T	UTR3	ZNF281	NM_001281294:c.*739_*740insA;NM_001281293:c.*739_*740insA;NM_012482:c.*739_*740insA	.	.	0.95167159	0.04829939	2.90E-05	.	0.94229	0.26731	-0.400392389	26.85185185	55.86461	1.50094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.68	81	chr1	200375406	chr1:200375406	C	CT	11.68	PASS	AN=0;DP=81	GT	0/1
chr1	204168378	204168378	A	-	exonic	GOLT1A	.	frameshift deletion	GOLT1A:NM_198447:exon4:c.305delT:p.F102Sfs*35	0.038757883	0.838243926	0.122998191	.	0.11431	0.59876	-0.339715008	30.06605331	18.54855	0.64184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	206	chr1	204168377	chr1:204168377	GA	G	61	PASS	AN=2;DP=206	GT	0/1
chr1	205719177	205719177	C	-	UTR5	NUCKS1	NM_022731:c.-76delG	.	.	0.979237658	0.020744772	1.76E-05	.	0.90068	0.13281	-0.119252484	44.53880632	4.59039	0.16497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	943	chr1	205719176	chr1:205719176	AC	A	128	PASS	AN=2;DP=943	GT	0/1
chr1	207787733	207787733	-	T	intronic	CR1	.	.	.	9.34E-08	0.999999848	5.90E-08	.	0.0878	.	.	.	3621.79634	11.67146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	262	chr1	207787733	chr1:207787733	C	CT	55	PASS	AN=2;DP=262	GT	0/1
chr1	207888640	207888640	-	T	intronic	CR1L	.	.	.	3.56E-15	0.020225564	0.979774436	.	0.06963	.	3.872389272	99.64614296	2178.56335	8.59961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	233	chr1	207888640	chr1:207888640	C	CT	78	PASS	AN=2;DP=233	GT	0/1
chr1	207930564	207930564	-	T	intronic	CD46	.	.	.	0.000191603	0.974855327	0.02495307	DISEASE: Hemolytic uremic syndrome atypical 2 (AHUS2) [MIM:612922]: An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure and absence of episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease. {ECO:0000269|PubMed:16386793, ECO:0000269|PubMed:16621965, ECO:0000269|PubMed:20513133}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Other genes may play a role in modifying the phenotype. Patients with CD46 mutations seem to have an overall better prognosis compared to patients carrying CFH mutations.; 	0.10479	0.17659	0.439181676	77.69521113	55.53796	1.49781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	121	chr1	207930564	chr1:207930564	C	CT	65	PASS	AN=2;DP=121	GT	0/1
chr1	209880509	209880509	A	-	ncRNA_intronic	LOC101930114	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	42	chr1	209880508	chr1:209880508	GA	G	119	PASS	AN=2;DP=42	GT	0/1
chr1	209936964	209936964	-	CA	intronic	TRAF3IP3	.	.	.	1.38E-06	0.989497509	0.010501115	.	0.25181	0.12101	0.286674996	71.49681529	267.89298	3.51107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	52	chr1	209936964	chr1:209936964	T	TCA	116	PASS	AN=2;DP=52	GT	0/1
chr1	215972220	215972220	C	A	intronic	USH2A	.	.	.	3.68E-43	0.999989236	1.08E-05	DISEASE: Usher syndrome 2A (USH2A) [MIM:276901]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:10729113, ECO:0000269|PubMed:10738000, ECO:0000269|PubMed:10909849, ECO:0000269|PubMed:11311042, ECO:0000269|PubMed:12112664, ECO:0000269|PubMed:12525556, ECO:0000269|PubMed:14970843, ECO:0000269|PubMed:15015129, ECO:0000269|PubMed:15025721, ECO:0000269|PubMed:15241801, ECO:0000269|PubMed:15325563, ECO:0000269|PubMed:17085681, ECO:0000269|PubMed:17405132, ECO:0000269|PubMed:18273898, ECO:0000269|PubMed:18452394, ECO:0000269|PubMed:19683999, ECO:0000269|PubMed:19737284, ECO:0000269|PubMed:20309401, ECO:0000269|PubMed:20440071, ECO:0000269|PubMed:20507924, ECO:0000269|PubMed:21593743, ECO:0000269|PubMed:21686329, ECO:0000269|PubMed:22004887, ECO:0000269|PubMed:23737954, ECO:0000269|PubMed:9624053}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 39 (RP39) [MIM:613809]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:10775529, ECO:0000269|PubMed:12112664, ECO:0000269|PubMed:12427073, ECO:0000269|PubMed:15325563, ECO:0000269|PubMed:16098008, ECO:0000269|PubMed:17296898, ECO:0000269|PubMed:20507924, ECO:0000269|PubMed:21686329, ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:24227914}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15836	.	4.179636958	99.70511913	6401.91635	16.71188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	84	chr1	215972220	chr1:215972220	C	A	103	PASS	AN=2;DP=84	GT	0/1
chr1	217784432	217784432	C	-	intronic	GPATCH2	.	.	.	9.66E-05	0.986025695	0.013877705	.	0.35805	.	0.108486928	61.90728946	309.35921	3.7445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	325	chr1	217784431	chr1:217784431	AC	A	92	PASS	AN=2;DP=325	GT	0/1
chr1	223168205	223168205	-	T	intronic	DISP1	.	.	.	4.23E-06	0.997859918	0.002135849	.	0.16068	0.11183	0.369203982	74.77589054	4506.07665	13.48325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	225	chr1	223168205	chr1:223168205	C	CT	72	PASS	AN=2;DP=225	GT	0/1
chr1	223962513	223962513	-	T	intronic	CAPN2	.	.	.	1.62E-11	0.793333331	0.206666669	.	0.2116	0.29838	0.7164803	85.82802548	3510.65552	11.43339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	192	chr1	223962513	chr1:223962513	C	CT	65	PASS	AN=2;DP=192	GT	0/1
chr1	228597036	228597036	C	-	intronic	TRIM17	.	.	.	2.40E-05	0.744751518	0.255224452	.	0.10342	0.18426	-0.21856543	37.66218448	129.33213	2.47962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	837	chr1	228597035	chr1:228597035	TC	T	79	PASS	AN=2;DP=837	GT	0/1
chr1	235311773	235311773	A	-	intronic	RBM34	.	.	.	7.95E-09	0.270393494	0.729606498	.	0.5887	.	-0.844966979	11.1759849	50.60593	1.40016	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	210	chr1	235311772	chr1:235311772	GA	G	79	PASS	AN=2;DP=210	GT	0/1
chr1	236724605	236724605	G	T	intronic	HEATR1	.	.	.	0.999999993	6.78E-09	9.22E-25	.	0.09748	0.08985	2.322745612	98.36635999	19763.61088	30.12571	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	152	118	chr1	236724605	chr1:236724605	G	T	152	PASS	AN=2;DP=118	GT	0/1
chr1	237969493	237969493	-	T	exonic	RYR2	.	frameshift insertion	RYR2:NM_001035:exon99:c.14209dupT:p.A4740Cfs*55	0.999999934	6.56E-08	1.25E-37	DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:11159936}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:11157710, ECO:0000269|PubMed:12093772, ECO:0000269|PubMed:12106942, ECO:0000269|PubMed:15046072, ECO:0000269|PubMed:15046073, ECO:0000269|PubMed:15466642, ECO:0000269|PubMed:15544015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27314	0.27889	-5.869562633	0.053078556	1401.64962	6.99815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	236	chr1	237969493	chr1:237969493	C	CT	71	PASS	AN=2;DP=236	GT	0/1
chr1	237982282	237982282	-	A	intronic	RYR2	.	.	.	0.999999934	6.56E-08	1.25E-37	DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:11159936}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:11157710, ECO:0000269|PubMed:12093772, ECO:0000269|PubMed:12106942, ECO:0000269|PubMed:15046072, ECO:0000269|PubMed:15046073, ECO:0000269|PubMed:15466642, ECO:0000269|PubMed:15544015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27314	0.27889	-5.869562633	0.053078556	1401.64962	6.99815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	175	chr1	237982282	chr1:237982282	G	GA	69	PASS	AN=2;DP=175	GT	0/1
chr1	243594955	243594955	-	T	intronic	SDCCAG8	.	.	.	1.33E-07	0.987717896	0.012281972	DISEASE: Bardet-Biedl syndrome 16 (BBS16) [MIM:615993]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:20835237, ECO:0000269|PubMed:22626039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13767	0.11503	-0.154246007	42.22694032	1944.53595	8.11749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	305	chr1	243594954	chr1:243594954	AT	ATT,A,ATTT	93	PASS	AN=2;DP=305	GT	0/1
chr1	243594955	243594955	T	-	intronic	SDCCAG8	.	.	.	1.33E-07	0.987717896	0.012281972	DISEASE: Bardet-Biedl syndrome 16 (BBS16) [MIM:615993]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:20835237, ECO:0000269|PubMed:22626039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13767	0.11503	-0.154246007	42.22694032	1944.53595	8.11749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	305	chr1	243594954	chr1:243594954	AT	ATT,A,ATTT	93	PASS	AN=2;DP=305	GT	0/1
chr1	243594955	243594955	-	TT	intronic	SDCCAG8	.	.	.	1.33E-07	0.987717896	0.012281972	DISEASE: Bardet-Biedl syndrome 16 (BBS16) [MIM:615993]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:20835237, ECO:0000269|PubMed:22626039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13767	0.11503	-0.154246007	42.22694032	1944.53595	8.11749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	305	chr1	243594954	chr1:243594954	AT	ATT,A,ATTT	93	PASS	AN=2;DP=305	GT	0/1
chr1	245017680	245017680	C	T	UTR3	HNRNPU	NM_004501:c.*72G>A;NM_031844:c.*72G>A	.	.	0.999903323	9.67E-05	7.22E-12	.	0.51398	0.38821	-0.60427181	17.74593064	41.32875	1.20799	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	286	chr1	245017680	chr1:245017680	C	T	91	PASS	AN=2;DP=286	GT	0/1
chr1	249142462	249142462	G	A	exonic	ZNF672	.	nonsynonymous SNV	ZNF672:NM_024836:exon4:c.G989A:p.R330Q	0.000127541	0.626900007	0.372972452	.	0.31122	.	.	.	21.60164	0.72631	0.952	0.021	T	0.629	0.383	P	0.08	0.274	B	0.646	0.106	U	1.000	0.182	N	0.15	0.089	N	1.23	0.369	T	1.86	0.005	N	0.19	0.232	-1.055	0.131	T	0.035	0.151	T	0.009	0.234	T	1.861	0.284	15.35	0.945	0.244	0.278	0.232	N	c	-0.594	-0.597	1.000	0.413	0.672	0.522	0	0.971	0.187	-1.519	0.023	0.017	0.142	0.000	0.063	0.989	0.536	3.722	0.079	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	70	537	chr1	249142462	chr1:249142462	G	A	70	PASS	AN=2;DP=537	GT	0/1
chr2	10095020	10095020	-	T	intronic	GRHL1	.	.	.	0.983150779	0.016849134	8.72E-08	.	0.18056	0.20109	-0.113792788	45.25831564	1942.58495	8.11174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	310	chr2	10095020	chr2:10095020	G	GT	87	PASS	AN=2;DP=310	GT	0/1
chr2	29004734	29004734	-	T	intronic	PPP1CB	.	.	.	0.997194974	0.002804895	1.31E-07	.	0.75832	.	-0.09720619	46.20193442	2.60658	0.09519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	331	chr2	29004734	chr2:29004734	A	AT	88	PASS	AN=2;DP=331	GT	0/1
chr2	36776617	36776617	T	-	UTR3	CRIM1	NM_016441:c.*773delT	.	.	0.977883079	0.022116914	6.98E-09	.	0.26394	.	-1.100469982	6.929700401	649.0811	5.11079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	159	chr2	36776616	chr2:36776616	CT	C	133	PASS	AN=2;DP=159	GT	0/1
chr2	39234343	39234343	A	-	intronic	SOS1	.	.	.	0.999999895	1.05E-07	1.77E-20	DISEASE: Noonan syndrome 4 (NS4) [MIM:610733]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. Some patients with NS4 have polyarticular villonodular synovitis. {ECO:0000269|PubMed:17143282, ECO:0000269|PubMed:17143285, ECO:0000269|PubMed:19020799, ECO:0000269|PubMed:19438935, ECO:0000269|PubMed:19953625, ECO:0000269|PubMed:20673819, ECO:0000269|PubMed:20683980, ECO:0000269|PubMed:21387466}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.72054	0.38414	-0.995664936	8.539749941	106.78667	2.24216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	240	chr2	39234342	chr2:39234342	TA	T	67	PASS	AN=2;DP=240	GT	0/1
chr2	44445605	44445605	T	-	intronic	PPM1B	.	.	.	0.109620711	0.884012724	0.006366565	.	0.99971	0.21173	-0.490397599	22.50530786	53.58105	1.456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	137	chr2	44445604	chr2:44445604	GT	G,GTT	107	PASS	AN=2;DP=137	GT	0/1
chr2	44445605	44445605	-	T	intronic	PPM1B	.	.	.	0.109620711	0.884012724	0.006366565	.	0.99971	0.21173	-0.490397599	22.50530786	53.58105	1.456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	137	chr2	44445604	chr2:44445604	GT	G,GTT	107	PASS	AN=2;DP=137	GT	0/1
chr2	48941191	48941191	T	A	exonic	LHCGR	.	nonsynonymous SNV	LHCGR:NM_000233:exon7:c.A539T:p.K180I	2.80E-08	0.490421431	0.509578541	DISEASE: Luteinizing hormone resistance (LHR) [MIM:238320]: An autosomal recessive disorder characterized by unresponsiveness to luteinizing hormone, defective sexual development in males, and defective follicular development and ovulation, amenorrhea and infertility in females. Two forms of the disorder have been defined in males. Type 1 is a severe form characterized by complete 46,XY male pseudohermaphroditism, low testosterone and high luteinizing hormone levels, total lack of responsiveness to luteinizing and chorionic gonadotropin hormones, lack of breast development, and absent development of secondary male sex characteristics. Type 2, a milder form, displays a broader range of phenotypic expression ranging from micropenis to severe hypospadias. {ECO:0000269|PubMed:12050206, ECO:0000269|PubMed:15372531, ECO:0000269|PubMed:15472221, ECO:0000269|PubMed:19551906, ECO:0000269|PubMed:7719343, ECO:0000269|PubMed:8559204, ECO:0000269|PubMed:9215288, ECO:0000269|PubMed:9514160, ECO:0000269|PubMed:9626144, ECO:0000269|PubMed:9626653}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13036	0.42555	0.356452144	74.62845011	1328.76039	6.85266	0.034	0.574	D	1.0	0.899	D	0.999	0.916	D	0.000	0.629	D	1.000	0.810	D	0.995	0.252	L	-1.57	0.819	D	-3.84	0.823	D	0.829	0.831	0.180	0.856	D	0.618	0.865	D	0.274	0.900	D	4.738	0.635	24.7	0.995	0.706	0.939	0.593	D	c	0.638	0.645	1.000	0.489	0.487	0.133	0	5.52	0.821	5.074	0.640	1.061	0.807	1.000	0.715	0.994	0.587	14.976	0.708	Leucine-rich repeat domain, L domain-like	.	.	0.5	127	87	chr2	48941191	chr2:48941191	T	A	127	PASS	AN=2;DP=87	GT	0/1
chr2	56611386	56611386	-	T	intronic	CCDC85A	.	.	.	0.001735205	0.894912275	0.10335252	.	0.11972	0.09438	0.040529541	57.15380986	1143.32157	6.44627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	82	chr2	56611386	chr2:56611386	C	CT	86	PASS	AN=2;DP=82	GT	0/1
chr2	70463168	70463168	-	A	intronic	TIA1	.	.	.	0.832581092	0.167412892	6.02E-06	DISEASE: Welander distal myopathy (WDM) [MIM:604454]: An autosomal dominant disorder characterized by adult onset of distal muscle weakness predominantly affecting the distal long extensors of the hands, with slow progression to involve all small hand muscles and the lower legs. Skeletal muscle biopsy shows myopathic changes and prominent rimmed vacuoles. Rare homozygous patients showed earlier onset, faster progression, and proximal muscle involvement. {ECO:0000269|PubMed:23348830, ECO:0000269|PubMed:23401021}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.90768	0.26333	0.238945317	69.20853975	83.28929	1.94032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	169	chr2	70463168	chr2:70463168	T	TA	79	PASS	AN=2;DP=169	GT	0/1
chr2	74687410	74687410	C	-	exonic	WBP1	.	frameshift deletion	WBP1:NM_012477:exon4:c.412delC:p.P140Lfs*8	0.000303097	0.803000262	0.196696641	.	.	0.10512	-0.26993514	34.59542345	86.33658	1.98463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	779	chr2	74687409	chr2:74687409	AC	A	105	PASS	AN=2;DP=779	GT	0/1
chr2	74687542	74687542	-	C	exonic	WBP1	.	frameshift insertion	WBP1:NM_012477:exon4:c.545dupC:p.H185Sfs*4	0.000303097	0.803000262	0.196696641	.	.	0.10512	-0.26993514	34.59542345	86.33658	1.98463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	1009	chr2	74687542	chr2:74687542	G	GC	79	PASS	AN=2;DP=1009	GT	0/1
chr2	74906846	74906846	C	-	exonic	SEMA4F	.	frameshift deletion	SEMA4F:NM_001271661:exon10:c.1358delC:p.R455Gfs*8,SEMA4F:NM_001271662:exon13:c.1724delC:p.R577Gfs*8,SEMA4F:NM_004263:exon14:c.1823delC:p.R610Gfs*8	6.74E-10	0.857591603	0.142408397	.	0.0811	0.09449	-1.061810361	7.519462137	110.21044	2.28329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	417	chr2	74906845	chr2:74906845	AC	A	76	PASS	AN=2;DP=417	GT	0/1
chr2	87211799	87211799	A	G	intronic	RGPD1;RGPD2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	370	chr2	87211799	chr2:87211799	A	G	106	PASS	AN=2;DP=370	GT	0/1
chr2	87211809	87211809	C	A	intronic	RGPD1;RGPD2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	414	chr2	87211809	chr2:87211809	C	A	83	PASS	AN=2;DP=414	GT	0/1
chr2	87355912	87355912	C	T	intergenic	LOC285074;MIR4771-2	dist=52376;dist=65997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	166	chr2	87355912	chr2:87355912	C	T	131	PASS	AN=2;DP=166	GT	0/1
chr2	91795525	91795525	G	T	intergenic	NONE;LOC654342	dist=NONE;dist=29184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	1071	chr2	91795525	chr2:91795525	G	T	109	PASS	AN=2;DP=1071	GT	0/1
chr2	96457946	96457946	T	C	intergenic	TRIM43;LINC00342	dist=192427;dist=14854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	173	221	chr2	96457946	chr2:96457946	T	C	173	PASS	AN=2;DP=221	GT	0/1
chr2	97827782	97827782	T	C	intronic	ANKRD36	.	.	.	2.12E-19	0.086362931	0.913637069	.	.	.	.	.	4272.72254	12.99655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	169	chr2	97827782	chr2:97827782	T	C	.	PASS	AN=0;DP=169	GT	0/1
chr2	98872571	98872571	T	-	intronic	VWA3B	.	.	.	3.27E-18	0.596776822	0.403223178	DISEASE: Note=Defects in VWA3B may be a cause of cerebellar ataxia with intellectual disability. {ECO:0000269|PubMed:26157035}.; 	0.09166	.	1.322735566	94.07879217	1748.74917	7.72022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	281	chr2	98872570	chr2:98872570	CT	C	110	PASS	AN=2;DP=281	GT	0/1
chr2	101640087	101640087	T	-	intronic	TBC1D8	.	.	.	5.26E-07	0.999927627	7.18E-05	.	0.16485	0.13045	-1.006844617	8.209483369	2278.58196	8.83254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	242	chr2	101640086	chr2:101640086	GT	G,GTT	59	PASS	AN=2;DP=242	GT	0/1
chr2	101640087	101640087	-	T	intronic	TBC1D8	.	.	.	5.26E-07	0.999927627	7.18E-05	.	0.16485	0.13045	-1.006844617	8.209483369	2278.58196	8.83254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	242	chr2	101640086	chr2:101640086	GT	G,GTT	59	PASS	AN=2;DP=242	GT	0/1
chr2	109374849	109374849	-	T	intronic	RANBP2	.	.	.	0.999999999	1.49E-09	4.67E-27	DISEASE: Encephalopathy, acute, infection-induced, 3 (IIAE3) [MIM:608033]: A rapidly progressive encephalopathy manifesting in susceptible individuals with seizures and coma. It can occur within days in otherwise healthy children after common viral infections such as influenza and parainfluenza, without evidence of viral infection of the brain or inflammatory cell infiltration. Brain T2-weighted magnetic resonance imaging reveals characteristic symmetric lesions present in the thalami, pons and brainstem. {ECO:0000269|PubMed:19118815}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in the RANBP2 gene predispose to IIAE3, but by themselves are insufficient to make the phenotype fully penetrant; additional genetic and environmental factors are required (PubMed:19118815). {ECO:0000269|PubMed:19118815}.; 	0.93164	0.52169	-1.538551197	3.33215381	1024.97017	6.15454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	335	chr2	109374849	chr2:109374849	A	AT	78	PASS	AN=2;DP=335	GT	0/1
chr2	114400755	114400755	-	T	UTR3	RABL2A	NM_001306158:c.*1049_*1050insT;NM_013412:c.*1049_*1050insT;NM_001306161:c.*1049_*1050insT	.	.	0.940339178	0.059419131	0.000241691	.	.	0.09824	0.283038099	71.26680821	604.99814	4.97813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	404	chr2	114400755	chr2:114400755	C	CT	95	PASS	AN=2;DP=404	GT	0/1
chr2	131947396	131947396	T	-	intergenic	PLEKHB2;POTEE	dist=39971;dist=28528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	312	chr2	131947395	chr2:131947395	AT	A	82	PASS	AN=2;DP=312	GT	0/1
chr2	157186619	157186619	G	T	exonic	NR4A2	.	stopgain	NR4A2:NM_006186:exon3:c.C80A:p.S27X	0.991432866	0.008565133	2.00E-06	.	0.64744	0.60715	-0.626318434	17.03231894	29.24717	0.93603	.	.	.	.	.	.	.	.	.	0.010	0.301	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.397	0.967	36	0.990	0.491	0.958	0.660	D	c	0.937	0.824	1.000	0.747	0.549	0.223	0	5.43	0.789	6.401	0.730	1.048	0.713	1.000	0.715	1.000	0.888	19.013	0.928	.	.	.	0.5	116	247	chr2	157186619	chr2:157186619	G	T	116	PASS	AN=2;DP=247	GT	0/1
chr2	163045690	163045690	-	A	intronic	FAP	.	.	.	3.27E-11	0.974918303	0.025081697	.	0.37525	0.24378	-1.105907904	6.86482661	161.12606	2.77308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	134	chr2	163045690	chr2:163045690	G	GA	53	PASS	AN=2;DP=134	GT	0/1
chr2	165365287	165365287	-	T	exonic	GRB14	.	frameshift insertion	GRB14:NM_001303422:exon6:c.630dupA:p.H211Tfs*5,GRB14:NM_004490:exon7:c.891dupA:p.H298Tfs*5	0.096601217	0.903069559	0.000329224	.	0.8157	0.1643	-0.178111357	40.44585987	4317.13537	13.08149	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	214	chr2	165365287	chr2:165365287	G	GT	64	PASS	AN=2;DP=214	GT	0/1
chr2	178988920	178988920	A	-	exonic	RBM45	.	frameshift deletion	RBM45:NM_152945:exon8:c.1135delA:p.A382Lfs*6	0.000125349	0.990228317	0.009646334	.	0.1004	0.11409	-0.271755481	34.31823543	44.33184	1.2715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	308	chr2	178988919	chr2:178988919	CA	C	95	PASS	AN=2;DP=308	GT	0/1
chr2	182775403	182775403	-	T	intronic	SSFA2	.	.	.	7.68E-05	0.999757987	0.000165174	.	0.16545	0.10002	0.235100429	68.59518754	2237.71105	8.72526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	439	chr2	182775402	chr2:182775402	GT	GTT,G	120	PASS	AN=2;DP=439	GT	0/1
chr2	182775403	182775403	T	-	intronic	SSFA2	.	.	.	7.68E-05	0.999757987	0.000165174	.	0.16545	0.10002	0.235100429	68.59518754	2237.71105	8.72526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	439	chr2	182775402	chr2:182775402	GT	GTT,G	120	PASS	AN=2;DP=439	GT	0/1
chr2	186629349	186629349	G	A	intronic	FSIP2	.	.	.	3.22E-08	0.999967049	3.29E-05	.	0.05212	0.07622	.	.	5663.99441	15.56525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	75	chr2	186629349	chr2:186629349	G	A	124	PASS	AN=2;DP=75	GT	0/1
chr2	196891589	196891589	C	T	exonic	DNAH7	.	nonsynonymous SNV	DNAH7:NM_018897:exon7:c.G562A:p.V188I	1.04E-47	0.815068072	0.184931928	.	0.23862	0.10363	5.09315636	99.81717386	6415.17778	16.77483	1.0	0.096	T	0.027	0.182	B	0.019	0.176	B	0.000	0.523	D	1.000	0.513	D	1.035	0.257	L	2.2	0.186	T	-0.04	0.140	N	0.328	0.471	-1.074	0.085	T	0.038	0.165	T	0.004	0.088	T	1.570	0.250	13.69	0.997	0.773	0.789	0.387	D	c	-0.416	-0.236	1.000	0.415	0.487	0.133	0	5.92	0.955	1.692	0.371	0.935	0.490	0.951	0.329	0.208	0.219	19.912	0.970	.	.	.	0.5	81	201	chr2	196891589	chr2:196891589	C	T	81	PASS	AN=2;DP=201	GT	0/1
chr2	197649613	197649613	-	T	exonic	GTF3C3	.	frameshift insertion	GTF3C3:NM_001206774:exon8:c.1081dupA:p.T361Nfs*10,GTF3C3:NM_012086:exon8:c.1081dupA:p.T361Nfs*10	5.36E-06	0.999685126	0.000309515	.	0.34288	0.24605	-0.422438699	25.64284029	26.74564	0.86554	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	329	chr2	197649613	chr2:197649613	G	GT	77	PASS	AN=2;DP=329	GT	0/1
chr2	202978199	202978199	T	-	ncRNA_intronic	LOC729224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	346	chr2	202978198	chr2:202978198	GT	G,GTTT	117	PASS	AN=2;DP=346	GT	0/1
chr2	202978199	202978199	-	TT	ncRNA_intronic	LOC729224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	346	chr2	202978198	chr2:202978198	GT	G,GTTT	117	PASS	AN=2;DP=346	GT	0/1
chr2	225422591	225422591	G	C	intronic	CUL3	.	.	.	0.974063405	0.025936543	5.11E-08	DISEASE: Pseudohypoaldosteronism 2E (PHA2E) [MIM:614496]: An autosomal dominant disorder characterized by severe hypertension, hyperkalemia, hyperchloremia, hyperchloremic metabolic acidosis, and correction of physiologic abnormalities by thiazide diuretics. {ECO:0000269|PubMed:22266938}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25175	0.18619	-0.139478553	43.29440906	1361.02638	6.92534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	76	chr2	225422591	chr2:225422591	G	C	111	PASS	AN=2;DP=76	GT	0/1
chr2	232577559	232577559	T	C	exonic	PTMA	.	stoploss	PTMA:NM_001099285:exon5:c.T334C:p.X112Q,PTMA:NM_002823:exon5:c.T331C:p.X111Q	0.377491926	0.576544202	0.045963872	.	.	.	-0.009020804	52.8544468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2.417	0.352	18.93	0.684	0.084	0.932	0.572	D	c	0.982	0.806	1.000	0.747	0.140	0.025	0	4.63	0.570	4.562	0.603	1.040	0.660	1.000	0.715	1.000	0.888	13.544	0.610	.	.	.	0.5	100	430	chr2	232577559	chr2:232577559	T	C	100	PASS	AN=2;DP=430	GT	0/1
chr2	241979571	241979571	C	T	exonic	SNED1	.	synonymous SNV	SNED1:NM_001080437:exon7:c.C1125T:p.C375C	0.98376281	0.01623719	1.33E-10	.	0.22403	0.13286	-1.379925048	4.364236848	4194.17391	12.86144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	132	chr2	241979571	chr2:241979571	C	T	69	PASS	AN=2;DP=132	GT	0/1
chr3	9987398	9987398	-	A	UTR3	PRRT3	NM_207351:c.*512_*513insT	.	.	0.658018522	0.341744429	0.000237049	.	0.10702	0.08913	.	.	3828.2537	12.1724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	358	chr3	9987398	chr3:9987398	G	GA	93	PASS	AN=2;DP=358	GT	0/1
chr3	38137959	38137959	-	T	intronic	DLEC1	.	.	.	6.45E-18	0.99562723	0.00437277	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note=The gene represented in this entry may be involved in disease pathogenesis. DLEC1 silencing due to promoter methylation and aberrant transcription are implicated in the development of lung cancer.; DISEASE: Esophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. {ECO:0000269|PubMed:10213508}. Note=The gene represented in this entry may be involved in disease pathogenesis. DLEC1 silencing due to promoter methylation and aberrant transcription may be implicated in the development of esophageal cancer.; 	0.98238	0.10873	0.161491526	64.92686954	3130.50362	10.64467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	141	chr3	38137959	chr3:38137959	G	GT	92	PASS	AN=2;DP=141	GT	0/1
chr3	40550121	40550121	-	T	intronic	ZNF620	.	.	.	6.83E-06	0.715071728	0.284921445	.	0.10981	.	0.350995466	74.37485256	198.29097	3.04284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10	73	chr3	40550121	chr3:40550121	C	CT	10	PASS	AN=0;DP=73	GT	0/1
chr3	57611367	57611367	-	A	UTR3	DENND6A	NM_152678:c.*2573_*2574insT	.	.	0.852272523	0.147727301	1.76E-07	.	0.26434	.	-0.0274281	51.65723048	40.37373	1.18488	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	30	chr3	57611367	chr3:57611367	T	TA	75	PASS	AN=2;DP=30	GT	0/1
chr3	57843748	57843748	-	T	intronic	SLMAP	.	.	.	0.999325965	0.000674035	6.78E-12	.	0.43101	0.11509	-1.155457828	6.168907761	40.3211	1.1843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	50	chr3	57843748	chr3:57843748	C	CT	110	PASS	AN=2;DP=50	GT	0/1
chr3	93722533	93722533	G	C	exonic	ARL13B	.	nonsynonymous SNV	ARL13B:NM_001174150:exon3:c.G161C:p.G54A,ARL13B:NM_182896:exon3:c.G161C:p.G54A,ARL13B:NM_001321328:exon4:c.G116C:p.G39A	1.39E-06	0.833651588	0.16634702	DISEASE: Joubert syndrome 8 (JBTS8) [MIM:612291]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. {ECO:0000269|PubMed:18674751}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06719	0.09956	-0.047654689	50.22410946	555.80587	4.78946	0.005	0.632	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	3.16	0.888	M	-1.49	0.812	T	-5.3	0.844	D	0.594	0.947	0.712	0.933	D	0.776	0.924	D	0.059	0.677	D	5.227	0.706	25.6	0.999	0.933	0.993	0.938	D	c	1.085	1.033	1.000	0.747	0.638	0.428	0	5.93	0.959	8.089	0.893	0.998	0.613	1.000	0.715	0.998	0.697	20.349	0.988	P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	.	.	0.5	101	789	chr3	93722533	chr3:93722533	G	C	101	PASS	AN=2;DP=789	GT	0/1
chr3	122811188	122811188	-	T	intronic	PDIA5	.	.	.	1.00E-06	0.983714807	0.016284189	.	0.23723	0.1339	-0.953385901	9.206180703	310.15723	3.74607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	262	chr3	122811187	chr3:122811187	GT	GTT,G,GTTTTT	110	PASS	AN=2;DP=262	GT	0/1
chr3	122811188	122811188	T	-	intronic	PDIA5	.	.	.	1.00E-06	0.983714807	0.016284189	.	0.23723	0.1339	-0.953385901	9.206180703	310.15723	3.74607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	262	chr3	122811187	chr3:122811187	GT	GTT,G,GTTTTT	110	PASS	AN=2;DP=262	GT	0/1
chr3	122811188	122811188	-	TTTT	intronic	PDIA5	.	.	.	1.00E-06	0.983714807	0.016284189	.	0.23723	0.1339	-0.953385901	9.206180703	310.15723	3.74607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	262	chr3	122811187	chr3:122811187	GT	GTT,G,GTTTTT	110	PASS	AN=2;DP=262	GT	0/1
chr3	132363753	132363753	A	-	ncRNA_intronic	NPHP3-ACAD11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	157	chr3	132363752	chr3:132363752	TA	T	86	PASS	AN=2;DP=157	GT	0/1
chr3	148711906	148711906	-	T	intronic	GYG1	.	.	.	6.91E-07	0.4631179	0.536881409	DISEASE: Glycogen storage disease 15 (GSD15) [MIM:613507]: A metabolic disorder resulting in muscle weakness, associated with the glycogen depletion in skeletal muscle, and cardiac arrhythmia, associated with the accumulation of abnormal storage material in the heart. The skeletal muscle shows a marked predominance of slow-twitch, oxidative muscle fibers and mitochondrial proliferation. {ECO:0000269|PubMed:20357282}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polyglucosan body myopathy 2 (PGBM2) [MIM:616199]: A glycogen storage disease characterized by polyglucosan accumulation in muscle, and skeletal myopathy without cardiac involvement. Most patients manifest slowly progressive, hip girdle, shoulder girdle, and/or hand and leg muscle weakness. Polyglucosan contains abnormally long and poorly branched glucosyl chains and is variably resistant to digestion by alpha-amylase. {ECO:0000269|PubMed:25272951}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.17298	0.16384	-0.069700724	48.54328851	98.90905	2.15121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	196	chr3	148711906	chr3:148711906	G	GT	81	PASS	AN=2;DP=196	GT	0/1
chr3	160970544	160970544	T	-	intronic	NMD3	.	.	.	4.42E-05	0.991223131	0.008732642	.	0.07893	0.10797	-0.512444034	21.55579146	81.92408	1.91851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	271	chr3	160970543	chr3:160970543	AT	A	81	PASS	AN=2;DP=271	GT	0/1
chr3	174000599	174000599	T	-	UTR3	NLGN1	NM_014932:c.*1506delT	.	.	0.755797512	0.24411687	8.56E-05	.	0.34175	0.13453	-1.397999468	4.193205945	58.37576	1.54762	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	285	chr3	174000598	chr3:174000598	AT	A,ATT	71	PASS	AN=2;DP=285	GT	0/1
chr3	174000599	174000599	-	T	UTR3	NLGN1	NM_014932:c.*1506_*1507insT	.	.	0.755797512	0.24411687	8.56E-05	.	0.34175	0.13453	-1.397999468	4.193205945	58.37576	1.54762	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	285	chr3	174000598	chr3:174000598	AT	A,ATT	71	PASS	AN=2;DP=285	GT	0/1
chr3	179119110	179119110	-	A	intronic	GNB4	.	.	.	0.629775083	0.369918722	0.000306195	.	0.45415	0.12971	-0.029247611	51.40363293	17.25958	0.60544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	592	chr3	179119110	chr3:179119110	G	GA	93	PASS	AN=2;DP=592	GT	0/1
chr3	179525570	179525570	C	T	exonic	PEX5L	.	nonsynonymous SNV	PEX5L:NM_001349404:exon10:c.G992A:p.R331H,PEX5L:NM_001349401:exon11:c.G992A:p.R331H,PEX5L:NM_001256753:exon12:c.G1391A:p.R464H,PEX5L:NM_001349397:exon12:c.G1340A:p.R447H,PEX5L:NM_001349398:exon12:c.G1301A:p.R434H,PEX5L:NM_001349399:exon12:c.G992A:p.R331H,PEX5L:NM_001349410:exon12:c.G992A:p.R331H,PEX5L:NM_001256751:exon13:c.G1496A:p.R499H,PEX5L:NM_001256752:exon13:c.G1463A:p.R488H,PEX5L:NM_001256755:exon13:c.G1244A:p.R415H,PEX5L:NM_001256756:exon13:c.G992A:p.R331H,PEX5L:NM_001349392:exon13:c.G1535A:p.R512H,PEX5L:NM_001349396:exon13:c.G1367A:p.R456H,PEX5L:NM_001349406:exon13:c.G992A:p.R331H,PEX5L:NM_001349409:exon13:c.G992A:p.R331H,PEX5L:NM_001256750:exon14:c.G1562A:p.R521H,PEX5L:NM_001256754:exon14:c.G1439A:p.R480H,PEX5L:NM_001349388:exon14:c.G1640A:p.R547H,PEX5L:NM_001349390:exon14:c.G1628A:p.R543H,PEX5L:NM_001349391:exon14:c.G1538A:p.R513H,PEX5L:NM_001349393:exon14:c.G1535A:p.R512H,PEX5L:NM_001349394:exon14:c.G1445A:p.R482H,PEX5L:NM_001349395:exon14:c.G1439A:p.R480H,PEX5L:NM_001349408:exon14:c.G992A:p.R331H,PEX5L:NM_016559:exon14:c.G1568A:p.R523H,PEX5L:NM_001349386:exon15:c.G1733A:p.R578H,PEX5L:NM_001349387:exon15:c.G1640A:p.R547H,PEX5L:NM_001349389:exon15:c.G1634A:p.R545H	0.664004906	0.335985902	9.19E-06	.	0.15812	0.14485	-0.977252525	8.799245105	84.62819	1.95911	0.035	0.784	D	0.998	0.899	D	0.883	0.916	P	0.000	0.843	D	1	0.810	D	2.575	0.755	M	-1.4	0.805	T	-3.78	0.716	D	0.49	0.756	0.420	0.894	D	0.676	0.888	D	0.112	0.791	D	7.964	0.956	35	1.000	1.000	0.973	0.737	D	c	0.911	0.902	1.000	0.747	0.615	0.372	0	6.07	0.987	7.834	0.848	0.892	0.403	1.000	0.715	0.999	0.750	13.8	0.625	Tetratricopeptide repeat-containing domain|Tetratricopeptide-like helical domain	.	.	0.5	79	1066	chr3	179525570	chr3:179525570	C	T	79	PASS	AN=2;DP=1066	GT	0/1
chr3	180334046	180334046	T	-	intronic	CCDC39;TTC14	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	498	chr3	180334045	chr3:180334045	AT	A	83	PASS	AN=2;DP=498	GT	0/1
chr3	180665635	180665635	-	T	intronic	FXR1	.	.	.	0.999992198	7.80E-06	7.76E-14	.	0.83345	0.19444	-0.648365105	16.35999056	32.43007	1.01245	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	457	chr3	180665635	chr3:180665635	A	AT	83	PASS	AN=2;DP=457	GT	0/1
chr3	189705447	189705447	C	A	exonic	P3H2	.	nonsynonymous SNV	P3H2:NM_001134418:exon5:c.G424T:p.V142L,P3H2:NM_018192:exon5:c.G967T:p.V323L	.	.	.	.	0.14234	0.13152	-0.554717505	19.79830149	.	.	0.254	0.178	T	0.0	0.026	B	0.0	0.013	B	0.025	0.262	N	0.821	0.348	D	1.5	0.380	L	1.76	0.260	T	-0.97	0.258	N	0.141	0.168	-1.032	0.198	T	0.032	0.137	T	0.006	0.159	T	2.954	0.415	22.1	0.985	0.421	0.626	0.316	D	c	-0.577	-0.445	0.806	0.242	0.732	0.924	0	3.2	0.357	0.486	0.219	0.935	0.490	0.001	0.137	1.000	0.888	5.443	0.157	Tetratricopeptide-like helical domain	.	.	0.5	119	182	chr3	189705447	chr3:189705447	C	A	119	PASS	AN=2;DP=182	GT	0/1
chr3	195453249	195453249	T	C	exonic	MUC20	.	nonsynonymous SNV	MUC20:NM_001282506:exon2:c.T1775C:p.M592T,MUC20:NM_001291833:exon4:c.T1262C:p.M421T,MUC20:NM_020790:exon4:c.T1319C:p.M440T,MUC20:NM_152673:exon4:c.T1262C:p.M421T	.	.	.	.	.	0.05395	.	.	2482.91489	9.29408	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.830	0.091	N	1	0.206	N	-1.65	0.004	N	3.45	0.086	T	2.15	0.004	N	0.419	0.476	-0.954	0.403	T	0.007	0.026	T	.	.	.	-2.240	0.005	0.001	0.392	0.027	0.000	0.001	N	c	-1.579	-1.475	0.000	0.064	0.516	0.203	0	2.7	0.309	0.520	0.224	-2.118	0.004	0.000	0.063	0.000	0.016	7.490	0.265	.	.	.	0.5	.	123	chr3	195453249	chr3:195453249	T	C	.	PASS	AN=0;DP=123	GT	0/1
chr4	1245879	1245879	-	A	ncRNA_exonic	CTBP1-AS2	.	.	.	.	.	.	.	0.12776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	140	chr4	1245879	chr4:1245879	G	GA	88	PASS	AN=2;DP=140	GT	0/1
chr4	3769789	3769789	-	GGGGAGCTTTCCCAGAGACCC	UTR3	ADRA2C	NM_000683:c.*67_*68insGGGGAGCTTTCCCAGAGACCC	.	.	0.645951821	0.347840902	0.006207277	.	0.03325	0.09956	.	.	2173.15437	8.58195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	186	200	chr4	3769789	chr4:3769789	G	GGGGGAGCTTTCCCAGAGACCC	186	PASS	AN=2;DP=200	GT	0/1
chr4	9694448	9694448	C	G	intergenic	MIR548I2;DRD5	dist=136511;dist=88810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	175	chr4	9694448	chr4:9694448	C	G	147	PASS	AN=2;DP=175	GT	0/1
chr4	42618105	42618111	AAAAGCA	-	intronic	ATP8A1	.	.	.	0.999804446	0.000195554	5.58E-16	.	0.7991	0.1111	-0.641086234	16.6784619	389.36969	4.15685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	210	chr4	42618104	chr4:42618104	TAAAAGCA	T	69	PASS	AN=2;DP=210	GT	0/1
chr4	46314618	46314618	G	A	exonic	GABRA2	.	nonsynonymous SNV	GABRA2:NM_001114175:exon4:c.C371T:p.P124L,GABRA2:NM_001286827:exon4:c.C206T:p.P69L,GABRA2:NM_000807:exon5:c.C371T:p.P124L,GABRA2:NM_001330690:exon5:c.C371T:p.P124L	0.976963701	0.023031697	4.60E-06	.	0.31694	0.13475	-0.273576253	33.97027601	19.24152	0.66325	0.0	0.912	D	0.999	0.899	D	0.98	0.971	D	0.000	0.843	D	1	0.810	D	3.72	0.949	H	-5.0	0.985	D	-9.21	0.983	D	0.732	0.978	1.055	0.982	D	0.981	0.994	D	0.365	0.926	D	6.582	0.905	31	0.998	0.925	0.991	0.910	D	c	1.149	1.073	1.000	0.747	0.487	0.133	0	5.95	0.964	10.003	0.997	1.048	0.713	1.000	0.715	1.000	0.888	19.363	0.944	Neurotransmitter-gated ion-channel ligand-binding domain	.	.	0.5	137	71	chr4	46314618	chr4:46314618	G	A	137	PASS	AN=2;DP=71	GT	0/1
chr4	85715905	85715905	A	-	intronic	WDFY3	.	.	.	1	3.27E-17	4.23E-47	.	0.30087	0.1138	-2.817477736	0.62514744	213.17232	3.15112	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	154	chr4	85715904	chr4:85715904	TA	T	62	PASS	AN=2;DP=154	GT	0/1
chr4	90872905	90872905	A	-	intronic	MMRN1	.	.	.	9.35E-17	0.008835231	0.991164769	DISEASE: Note=Deficiency in multimerin-1 due to proteolytic degradation within the platelet alpha granules is associated with an autosomal dominant bleeding disorder (factor V Quebec). {ECO:0000269|PubMed:8652809}.; 	0.13885	0.16819	0.347157132	73.79688606	483.52708	4.52727	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	164	chr4	90872904	chr4:90872904	TA	T	62	PASS	AN=2;DP=164	GT	0/1
chr4	95198159	95198159	A	C	intronic	SMARCAD1	.	.	.	0.999996803	3.20E-06	1.79E-15	.	0.31853	0.24651	0.266447942	70.5826846	3025.83606	10.4458	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	187	chr4	95198159	chr4:95198159	A	C	129	PASS	AN=2;DP=187	GT	0/1
chr4	95494467	95494467	-	T	intronic	PDLIM5	.	.	.	0.012278281	0.986126064	0.001595655	.	0.21242	0.85159	1.335644081	94.24982307	220.34888	3.20885	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	209	chr4	95494467	chr4:95494467	A	AT	82	PASS	AN=2;DP=209	GT	0/1
chr4	109010246	109010246	A	-	intronic	LEF1	.	.	.	0.970134677	0.029856575	8.75E-06	.	0.92691	0.83191	0.196671391	67.19155461	108.65686	2.26268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	198	chr4	109010245	chr4:109010245	CA	C	83	PASS	AN=2;DP=198	GT	0/1
chr4	110737293	110737293	-	T	intronic	GAR1	.	.	.	0.81256498	0.187235181	0.000199839	.	0.15921	0.12543	0.347360312	73.97381458	48.13207	1.35139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	412	chr4	110737293	chr4:110737293	G	GT	77	PASS	AN=2;DP=412	GT	0/1
chr4	110971055	110971055	A	T	UTR3	ELOVL6	NM_024090:c.*1439T>A;NM_001130721:c.*1439T>A	.	.	0.971074457	0.028885714	3.98E-05	.	0.04544	0.03306	-0.207437529	38.2814343	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	147	chr4	110971055	chr4:110971055	A	T	72	PASS	AN=2;DP=147	GT	0/1
chr4	113578482	113578482	-	A	exonic	LARP7	.	nonframeshift insertion	LARP7:NM_015454:exon13:c.1749dupA:p.X583delinsX,LARP7:NM_016648:exon13:c.1749dupA:p.X583delinsX,LARP7:NM_001267039:exon15:c.1770dupA:p.X590delinsX	0.015080323	0.983738828	0.001180848	DISEASE: Alazami syndrome (ALAZS) [MIM:615071]: A syndromic form of primordial dwarfism, a condition characterized by severe growth restriction that has its onset in utero, and results in short stature and undersize. ALAZS patients manifest severe intellectual disability and distinct facial features including malar hypoplasia, deep-set eyes, broad nose, short philtrum, and macrostomia. Some patients have non-specific and inconsistent skeletal findings, for example, scoliosis and mild epiphyseal changes in the proximal phalanges, but no frank dysplasia. {ECO:0000269|PubMed:21937992, ECO:0000269|PubMed:22865833}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.4989	0.11332	0.242582624	69.45623968	898.22165	5.83839	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	157	chr4	113578482	chr4:113578482	G	GA	69	PASS	AN=2;DP=157	GT	0/1
chr4	144468476	144468476	T	-	intronic	SMARCA5	.	.	.	0.999999855	1.45E-07	9.54E-19	.	0.97888	0.36004	-0.979072682	8.752064166	9.86498	0.36124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	167	chr4	144468475	chr4:144468475	AT	A	71	PASS	AN=2;DP=167	GT	0/1
chr4	155471398	155471398	-	A	intronic	PLRG1	.	.	.	0.998224783	0.001775215	1.76E-09	.	0.55468	0.15289	-0.291981272	33.20358575	28.74018	0.91926	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	313	chr4	155471398	chr4:155471398	C	CA	54	PASS	AN=2;DP=313	GT	0/1
chr4	158281848	158281848	-	T	intronic	GRIA2	.	.	.	0.99550949	0.004490506	3.42E-09	.	0.3057	0.25829	-0.778825328	12.88039632	32.84712	1.01918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	111	chr4	158281848	chr4:158281848	G	GT	81	PASS	AN=2;DP=111	GT	0/1
chr4	173873171	173873171	G	T	intronic	GALNTL6	.	.	.	0.001655681	0.997152291	0.001192028	.	.	0.10877	-0.824740496	11.67728238	48.92451	1.36627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	321	chr4	173873171	chr4:173873171	G	T	112	PASS	AN=2;DP=321	GT	0/1
chr5	37051862	37051862	T	-	intronic	NIPBL	.	.	.	1	9.20E-18	1.38E-43	DISEASE: Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]: A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. Characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies. {ECO:0000269|PubMed:15146185, ECO:0000269|PubMed:15146186, ECO:0000269|PubMed:15318302, ECO:0000269|PubMed:20124326, ECO:0000269|PubMed:20358602, ECO:0000269|PubMed:21934712, ECO:0000269|PubMed:23254390, ECO:0000269|PubMed:25447906}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94334	0.10487	-2.44943873	1.014390186	759.33568	5.46172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	188	chr5	37051861	chr5:37051861	AT	A,ATT	87	PASS	AN=2;DP=188	GT	0/1
chr5	37051862	37051862	-	T	intronic	NIPBL	.	.	.	1	9.20E-18	1.38E-43	DISEASE: Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]: A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. Characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies. {ECO:0000269|PubMed:15146185, ECO:0000269|PubMed:15146186, ECO:0000269|PubMed:15318302, ECO:0000269|PubMed:20124326, ECO:0000269|PubMed:20358602, ECO:0000269|PubMed:21934712, ECO:0000269|PubMed:23254390, ECO:0000269|PubMed:25447906}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94334	0.10487	-2.44943873	1.014390186	759.33568	5.46172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	188	chr5	37051861	chr5:37051861	AT	A,ATT	87	PASS	AN=2;DP=188	GT	0/1
chr5	110284912	110284912	-	T	intergenic	SLC25A46;TSLP	dist=184038;dist=122478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	209	chr5	110284912	chr5:110284912	C	CT	76	PASS	AN=2;DP=209	GT	0/1
chr5	133948392	133948392	C	T	exonic	SAR1B	.	nonsynonymous SNV	SAR1B:NM_016103:exon4:c.G233A:p.G78E,SAR1B:NM_001033503:exon5:c.G233A:p.G78E	0.006300416	0.910141255	0.083558329	.	0.4566	0.14201	-0.229483771	36.86010852	11.40907	0.41222	0.001	0.912	D	0.998	0.715	D	0.979	0.728	D	0.000	0.629	D	1	0.810	D	4.555	0.992	H	-5.54	0.992	D	-7.04	0.946	D	0.986	0.991	0.998	0.972	D	0.988	0.997	D	0.688	0.974	D	7.223	0.946	34	0.998	0.887	0.993	0.935	D	c	1.138	1.048	1.000	0.747	0.732	0.924	0	5.95	0.964	7.893	0.858	0.920	0.431	1.000	0.715	0.997	0.653	20.393	0.990	P-loop containing nucleoside triphosphate hydrolase;P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	.	.	0.5	69	654	chr5	133948392	chr5:133948392	C	T	69	PASS	AN=2;DP=654	GT	0/1
chr5	133948430	133948430	G	A	exonic	SAR1B	.	synonymous SNV	SAR1B:NM_016103:exon4:c.C195T:p.T65T,SAR1B:NM_001033503:exon5:c.C195T:p.T65T	0.006300416	0.910141255	0.083558329	.	0.4566	0.14201	-0.229483771	36.86010852	11.40907	0.41222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	613	chr5	133948430	chr5:133948430	G	A	72	PASS	AN=2;DP=613	GT	0/1
chr5	140554539	140554539	C	T	exonic	PCDHB7	.	nonsynonymous SNV	PCDHB7:NM_018940:exon1:c.C2123T:p.A708V	1.30E-15	0.000818546	0.999181454	.	0.10741	.	1.63326524	96.08398207	4489.23646	13.44872	0.269	0.161	T	0.906	0.480	P	0.422	0.433	B	.	.	.	1	0.090	N	2.3	0.659	M	2.41	0.155	T	-3.32	0.660	D	0.159	0.191	-1.032	0.199	T	0.064	0.264	T	0.010	0.269	T	3.220	0.446	22.7	0.994	0.610	0.064	0.123	N	c	-0.107	-0.274	0.013	0.125	0.581	0.326	0	1.57	0.224	-0.928	0.041	-0.161	0.107	0.000	0.063	0.295	0.236	5.006	0.135	Cadherin, cytoplasmic C-terminal domain	.	.	0.5	87	1523	chr5	140554539	chr5:140554539	C	T	87	PASS	AN=2;DP=1523	GT	0/1
chr5	149473843	149473843	-	T	intronic	CSF1R	.	.	.	0.993497648	0.00650235	1.71E-09	DISEASE: Note=Aberrant expression of CSF1 or CSF1R can promote cancer cell proliferation, invasion and formation of metastases. Overexpression of CSF1 or CSF1R is observed in a significant percentage of breast, ovarian, prostate, and endometrial cancers.; DISEASE: Note=Aberrant expression of CSF1 or CSF1R may play a role in inflammatory diseases, such as rheumatoid arthritis, glomerulonephritis, atherosclerosis, and allograft rejection.; DISEASE: Leukoencephalopathy, diffuse hereditary, with spheroids (HDLS) [MIM:221820]: An autosomal dominant adult-onset rapidly progressive neurodegenerative disorder characterized by variable behavioral, cognitive, and motor changes. Patients often die of dementia within 6 years of onset. Brain imaging shows patchy abnormalities in the cerebral white matter, predominantly affecting the frontal and parietal lobes. {ECO:0000269|PubMed:22197934, ECO:0000269|PubMed:24532199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42433	0.52469	0.609894095	82.95588582	987.59415	6.06031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	197	chr5	149473843	chr5:149473843	G	GT	71	PASS	AN=2;DP=197	GT	0/1
chr5	149599129	149599131	CCG	-	UTR3	CAMK2A	NM_171825:c.*3144_*3142delCGG;NM_015981:c.*3144_*3142delCGG	.	.	0.998004221	0.001995777	2.34E-09	.	0.6957	0.38769	-0.538132194	20.26421326	1.83486	0.0579	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	96	chr5	149599128	chr5:149599128	CCCG	C	98	PASS	AN=2;DP=96	GT	0/1
chr5	158585721	158585721	G	T	exonic	RNF145	.	nonsynonymous SNV	RNF145:NM_001199380:exon11:c.C2039A:p.P680H,RNF145:NM_001199381:exon11:c.C2000A:p.P667H,RNF145:NM_001199382:exon11:c.C1991A:p.P664H,RNF145:NM_001199383:exon11:c.C1949A:p.P650H,RNF145:NM_144726:exon11:c.C2033A:p.P678H	0.663621979	0.336332443	4.56E-05	.	0.33859	.	-0.736552314	13.93606983	26.28405	0.85227	0.008	0.586	D	0.07	0.343	B	0.112	0.363	B	0.510	0.118	N	1	0.090	N	0.55	0.145	N	-1.36	0.801	T	-1.41	0.348	N	0.225	0.333	-0.779	0.564	T	0.270	0.641	T	0.078	0.731	D	1.234	0.214	11.92	0.941	0.236	0.152	0.186	N	c	-0.806	-0.840	1.000	0.747	0.707	0.730	0	-0.886	0.100	0.602	0.237	1.048	0.713	0.000	0.063	0.030	0.147	6.835	0.230	.	.	.	0.5	131	301	chr5	158585721	chr5:158585721	G	T	131	PASS	AN=2;DP=301	GT	0/1
chr5	158585960	158585960	G	A	exonic	RNF145	.	synonymous SNV	RNF145:NM_001199380:exon11:c.C1800T:p.T600T,RNF145:NM_001199381:exon11:c.C1761T:p.T587T,RNF145:NM_001199382:exon11:c.C1752T:p.T584T,RNF145:NM_001199383:exon11:c.C1710T:p.T570T,RNF145:NM_144726:exon11:c.C1794T:p.T598T	0.663621979	0.336332443	4.56E-05	.	0.33859	.	-0.736552314	13.93606983	26.28405	0.85227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	446	chr5	158585960	chr5:158585960	G	A	133	PASS	AN=2;DP=446	GT	0/1
chr5	177099140	177099140	T	A	ncRNA_exonic	LOC202181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	178	chr5	177099140	chr5:177099140	T	A	137	PASS	AN=2;DP=178	GT	0/1
chr6	11213467	11213467	-	A	intronic	NEDD9	.	.	.	0.534981125	0.464991213	2.77E-05	.	0.38853	0.2374	-0.371072278	28.22009908	279.64751	3.58344	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	160	chr6	11213467	chr6:11213467	G	GA	62	PASS	AN=2;DP=160	GT	0/1
chr6	17615492	17615492	-	T	UTR3	NUP153	NM_005124:c.*835_*836insA;NM_001278210:c.*835_*836insA;NM_001278209:c.*835_*836insA	.	.	0.999994457	5.54E-06	1.38E-15	.	0.98695	0.10551	0.839507251	88.23425336	6828.76712	17.57298	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	297	chr6	17615492	chr6:17615492	A	AT	92	PASS	AN=2;DP=297	GT	0/1
chr6	26406255	26406255	G	A	exonic	BTN3A1	.	synonymous SNV	BTN3A1:NM_001145008:exon3:c.G204A:p.V68V,BTN3A1:NM_001145009:exon3:c.G204A:p.V68V,BTN3A1:NM_007048:exon3:c.G204A:p.V68V,BTN3A1:NM_194441:exon3:c.G204A:p.V68V	8.65E-07	0.747593221	0.252405913	.	0.06787	0.07707	0.531004228	80.87992451	647.15095	5.10575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	159	chr6	26406255	chr6:26406255	G	A	.	PASS	AN=0;DP=159	GT	0/1
chr6	28352060	28352060	C	G	intergenic	ZKSCAN3;ZSCAN12	dist=15106;dist=4667	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	106	chr6	28352060	chr6:28352060	C	G	97	PASS	AN=2;DP=106	GT	0/1
chr6	28352670	28352670	C	G	intergenic	ZKSCAN3;ZSCAN12	dist=15716;dist=4057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	152	237	chr6	28352670	chr6:28352670	C	G	152	PASS	AN=2;DP=237	GT	0/1
chr6	28352758	28352758	C	G	intergenic	ZKSCAN3;ZSCAN12	dist=15804;dist=3969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	181	chr6	28352758	chr6:28352758	C	G	138	PASS	AN=2;DP=181	GT	0/1
chr6	35262830	35262830	-	A	intronic	ZNF76	.	.	.	5.07E-16	0.006453546	0.993546454	.	0.26454	0.10496	0.404185162	76.48619958	1199.49311	6.56948	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	174	chr6	35262830	chr6:35262830	C	CA	62	PASS	AN=2;DP=174	GT	0/1
chr6	37427378	37427378	G	A	exonic	CMTR1	.	nonsynonymous SNV	CMTR1:NM_015050:exon10:c.G1013A:p.R338H	0.999294924	0.000705076	7.57E-12	.	0.3161	0.11198	-1.087493118	7.106628922	28.34808	0.90802	0.161	0.272	T	1.0	0.899	D	0.945	0.664	D	0.000	0.843	D	1	0.810	D	-0.115	0.046	N	0.97	0.425	T	-1.12	0.289	N	0.762	0.766	-1.009	0.271	T	0.103	0.379	T	0.012	0.313	T	6.359	0.878	29.4	0.999	0.999	0.988	0.868	D	c	0.597	0.689	1.0	0.983	0.722	0.854	0	6.17	0.997	6.324	0.727	1.048	0.713	1.000	0.715	1.000	0.888	19.868	0.968	Ribosomal RNA methyltransferase FtsJ domain|RrmJ-type ribose 2-O-methyltransferase domain|S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	124	76	chr6	37427378	chr6:37427378	G	A	124	PASS	AN=2;DP=76	GT	0/1
chr6	50681703	50681703	-	T	UTR5	TFAP2D	NM_172238:c.-66_-65insT	.	.	0.981586998	0.018399928	1.31E-05	.	0.75149	0.14024	0.016664174	55.21939137	509.04894	4.62407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	361	chr6	50681703	chr6:50681703	A	AT	78	PASS	AN=2;DP=361	GT	0/1
chr6	80837242	80837242	-	T	intronic	BCKDHB	.	.	.	2.91E-06	0.767207619	0.232789471	DISEASE: Maple syrup urine disease 1B (MSUD1B) [MIM:248600]: A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated. {ECO:0000269|PubMed:11509994, ECO:0000269|PubMed:22326532, ECO:0000269|PubMed:8161368}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.21382	0.37665	-0.449946534	24.00330267	37.41729	1.11457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	96	chr6	80837242	chr6:80837242	A	AT	43	PASS	AN=2;DP=96	GT	0/1
chr6	107566721	107566721	C	T	intronic	PDSS2	.	.	.	1.90E-05	0.695884938	0.304096105	DISEASE: Coenzyme Q10 deficiency, primary, 3 (COQ10D3) [MIM:614652]: A fatal encephalomyopathic form of coenzyme Q10 deficiency with nephrotic syndrome. Coenzyme Q10 deficiency is an autosomal recessive disorder with variable manifestations consistent with 5 major phenotypes. The phenotypes include an encephalomyopathic form with seizures and ataxia; a multisystem infantile form with encephalopathy, cardiomyopathy and renal failure; a predominantly cerebellar form with ataxia and cerebellar atrophy; Leigh syndrome with growth retardation; and an isolated myopathic form. {ECO:0000269|PubMed:17186472}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07675	0.11464	-0.069700724	48.54328851	310.44253	3.74923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	223	chr6	107566721	chr6:107566721	C	T	60	PASS	AN=2;DP=223	GT	0/1
chr6	108214755	108214755	T	-	exonic	SEC63	.	frameshift deletion	SEC63:NM_007214:exon16:c.1605delA:p.K535Nfs*27	1.24E-05	0.999895028	9.25E-05	.	0.26756	0.15588	-0.578583623	18.71903751	221.36898	3.21909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	265	chr6	108214754	chr6:108214754	GT	G	72	PASS	AN=2;DP=265	GT	0/1
chr6	133119524	133119524	G	A	intronic	SLC18B1	.	.	.	3.95E-10	0.179498685	0.820501314	.	0.13733	.	-0.110153916	45.48832272	589.95485	4.92467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	164	chr6	133119524	chr6:133119524	G	A	144	PASS	AN=2;DP=164	GT	0/1
chr6	134490613	134490613	-	A	UTR3	SGK1	NM_001143678:c.*792_*793insT;NM_005627:c.*792_*793insT;NM_001291995:c.*792_*793insT;NM_001143677:c.*792_*793insT;NM_001143676:c.*792_*793insT	.	.	0.986448163	0.013551585	2.52E-07	.	0.67964	0.57708	-0.288341872	33.41589998	105.09569	2.21804	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	15.51	122	chr6	134490613	chr6:134490613	C	CA,CAA	15.51	PASS	AN=0;DP=122	GT	0/1/.
chr6	134490613	134490613	-	AA	UTR3	SGK1	NM_001143678:c.*792_*793insTT;NM_005627:c.*792_*793insTT;NM_001291995:c.*792_*793insTT;NM_001143677:c.*792_*793insTT;NM_001143676:c.*792_*793insTT	.	.	0.986448163	0.013551585	2.52E-07	.	0.67964	0.57708	-0.288341872	33.41589998	105.09569	2.21804	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	15.51	122	chr6	134490613	chr6:134490613	C	CA,CAA	15.51	PASS	AN=0;DP=122	GT	0/1/.
chr6	134758928	134758932	TCCTT	-	ncRNA_exonic	LINC01010	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	78	chr6	134758927	chr6:134758927	GTCCTT	G	136	PASS	AN=2;DP=78	GT	0/1
chr6	144081696	144081696	A	-	exonic	PHACTR2	.	frameshift deletion	PHACTR2:NM_001100164:exon5:c.613delA:p.N207Ifs*79,PHACTR2:NM_014721:exon5:c.580delA:p.N196Ifs*79	0.007389423	0.992472999	0.000137578	.	0.7271	0.09166	-0.045835247	50.34206181	1505.57685	7.21249	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	319	chr6	144081695	chr6:144081695	TA	T	69	PASS	AN=2;DP=319	GT	0/1
chr6	158508009	158508009	C	-	exonic	SYNJ2	.	frameshift deletion	SYNJ2:NM_001178088:exon22:c.2620delC:p.P876Lfs*4,SYNJ2:NM_003898:exon23:c.3331delC:p.P1113Lfs*4	3.52E-05	0.999960576	4.19E-06	.	0.23517	.	-1.902173	1.952111347	376.38515	4.09028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	420	chr6	158508008	chr6:158508008	AC	A	91	PASS	AN=2;DP=420	GT	0/1
chr7	1540023	1540023	G	A	intronic	INTS1	.	.	.	0.224121375	0.775878625	1.91E-10	.	0.15585	.	-5.050633482	0.070771408	422.05224	4.29253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	630	chr7	1540023	chr7:1540023	G	A	75	PASS	AN=2;DP=630	GT	0/1
chr7	6470058	6470058	-	T	intronic	DAGLB	.	.	.	1.65E-06	0.962595118	0.037403231	.	0.12004	0.10395	0.033039107	55.85633404	760.30438	5.46562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	127	chr7	6470058	chr7:6470058	C	CT	86	PASS	AN=2;DP=127	GT	0/1
chr7	6862017	6862017	-	A	intronic	CCZ1B	.	.	.	.	.	.	.	0.2431	.	0.881944684	89.02453409	2277.99326	8.83084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	542	chr7	6862017	chr7:6862017	G	GA	112	PASS	AN=2;DP=542	GT	0/1
chr7	11630197	11630197	C	T	exonic	THSD7A	.	nonsynonymous SNV	THSD7A:NM_015204:exon4:c.G1343A:p.R448H	0.999280749	0.000719251	1.10E-16	.	0.27361	0.08944	-1.308377521	4.865534324	3259.76198	10.88292	0.235	0.180	T	0.391	0.328	B	0.049	0.237	B	0.000	0.843	D	1	0.810	D	2.185	0.615	M	0.25	0.595	T	-0.84	0.229	N	0.532	0.764	-0.859	0.514	T	0.182	0.530	T	0.025	0.481	T	6.182	0.853	28.6	0.999	0.999	0.980	0.786	D	c	0.128	0.242	1.000	0.747	0.563	0.310	0	5.8	0.921	6.109	0.710	0.935	0.490	0.999	0.424	0.467	0.265	20.055	0.976	.	.	.	0.5	143	628	chr7	11630197	chr7:11630197	C	T	143	PASS	AN=2;DP=628	GT	0/1
chr7	33054388	33054388	T	C	exonic	NT5C3A	.	nonsynonymous SNV	NT5C3A:NM_001002010:exon9:c.A965G:p.D322G,NT5C3A:NM_001002009:exon10:c.A848G:p.D283G,NT5C3A:NM_016489:exon10:c.A848G:p.D283G,NT5C3A:NM_001166118:exon11:c.A812G:p.D271G	0.012372194	0.952227978	0.035399828	DISEASE: P5N deficiency (P5ND) [MIM:266120]: Autosomal recessive condition causing hemolytic anemia characterized by marked basophilic stippling and the accumulation of high concentrations of pyrimidine nucleotides within the erythrocyte. It is implicated in the anemia of lead poisoning and is possibly associated with learning difficulties. {ECO:0000269|PubMed:11369620, ECO:0000269|PubMed:12930399, ECO:0000269|PubMed:15238149, ECO:0000269|PubMed:15604219, ECO:0000269|PubMed:15968458, ECO:0000269|PubMed:16461318, ECO:0000269|PubMed:18499901, ECO:0000269|PubMed:25153905}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20158	0.29586	0.12689526	63.00424628	81.15003	1.90678	0.001	0.784	D	0.934	0.502	P	0.881	0.608	P	0.003	0.355	N	1	0.810	D	3.29	0.905	M	-2.5	0.892	D	-5.98	0.893	D	0.601	0.670	0.935	0.962	D	0.856	0.952	D	.	.	.	6.728	0.919	32	0.997	0.818	0.995	0.964	D	c	0.800	0.791	1.000	0.747	0.732	0.924	0	5.94	0.962	8.017	0.886	1.061	0.807	1.000	0.715	0.996	0.625	16.407	0.835	HAD-like domain	.	.	0.5	110	176	chr7	33054388	chr7:33054388	T	C	110	PASS	AN=2;DP=176	GT	0/1
chr7	47342723	47342723	C	T	exonic	TNS3	.	synonymous SNV	TNS3:NM_022748:exon22:c.G3282A:p.G1094G	0.999389291	0.000610709	1.08E-12	.	0.29297	0.14134	0.132151962	63.36400094	726.40943	5.35297	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	907	chr7	47342723	chr7:47342723	C	T	67	PASS	AN=2;DP=907	GT	0/1
chr7	63225779	63225779	C	T	intergenic	MIR4283-1;ZNF722P	dist=144232;dist=233405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	132	chr7	63225779	chr7:63225779	C	T	112	PASS	AN=2;DP=132	GT	0/1
chr7	66463196	66463196	T	-	intronic	TYW1	.	.	.	0.000457249	0.999231545	0.000311206	.	0.12951	0.08688	-1.173870472	5.99197924	2883.67083	10.17398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	672	chr7	66463195	chr7:66463195	AT	A	127	PASS	AN=2;DP=672	GT	0/1
chr7	66703238	66703238	-	T	intronic	TYW1	.	.	.	0.000457249	0.999231545	0.000311206	.	0.12951	0.08688	-1.173870472	5.99197924	2883.67083	10.17398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	495	chr7	66703238	chr7:66703238	A	AT	99	PASS	AN=2;DP=495	GT	0/1
chr7	76632802	76632802	T	C	ncRNA_intronic	DTX2P1-UPK3BP1-PMS2P11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	332	chr7	76632802	chr7:76632802	T	C	86	PASS	AN=2;DP=332	GT	0/1
chr7	77006579	77006579	G	T	intronic	GSAP	.	.	.	3.60E-16	0.241435267	0.758564733	.	.	.	0.268267497	70.64166077	2346.20682	8.97223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	282	chr7	77006579	chr7:77006579	G	T	94	PASS	AN=2;DP=282	GT	0/1
chr7	77221481	77221481	-	T	intronic	PTPN12	.	.	.	0.999459859	0.000540141	9.66E-11	.	0.37635	0.16791	-0.488577883	22.64685067	1762.97619	7.75318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	135	chr7	77221481	chr7:77221481	A	AT	76	PASS	AN=2;DP=135	GT	0/1
chr7	86823977	86823977	-	T	intronic	DMTF1	.	.	.	0.956216303	0.043783659	3.80E-08	.	0.56131	0.12154	-0.111973265	45.35857514	283.65163	3.60477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	104	chr7	86823977	chr7:86823977	A	AT	42	PASS	AN=2;DP=104	GT	0/1
chr7	87760688	87760688	-	GAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG	exonic	ADAM22	.	stopgain	ADAM22:NM_001324417:exon11:c.927_928insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y314_I869delinsQDYKTPFMETSLSFS,ADAM22:NM_001324418:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_I964delinsQDYKTPFMETSLSFS,ADAM22:NM_001324419:exon11:c.927_928insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y314_I963delinsQDYKTPFMETSLSFS,ADAM22:NM_001324420:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_I935delinsQDYKTPFMETSLSFS,ADAM22:NM_001324421:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_A890delinsQDYKTPFMETSLSFS,ADAM22:NM_004194:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_E859delinsQDYKTPFMETSLSFS,ADAM22:NM_016351:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_I870delinsQDYKTPFMETSLSFS,ADAM22:NM_021721:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_E823delinsQDYKTPFMETSLSFS,ADAM22:NM_021722:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_I899delinsQDYKTPFMETSLSFS,ADAM22:NM_021723:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_I906delinsQDYKTPFMETSLSFS	0.999388899	0.000611101	2.19E-13	.	0.32606	0.10251	-0.551080959	19.93394669	868.56657	5.7407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	231	chr7	87760688	chr7:87760688	T	TGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG,TGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG	56	PASS	AN=2;DP=231	GT	0/1
chr7	87760688	87760688	-	GAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG	exonic	ADAM22	.	stopgain	ADAM22:NM_001324417:exon11:c.927_928insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K313Nfs*12,ADAM22:NM_001324418:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_001324419:exon11:c.927_928insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K313Nfs*12,ADAM22:NM_001324420:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_001324421:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_004194:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_016351:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_021721:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_021722:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_021723:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12	0.999388899	0.000611101	2.19E-13	.	0.32606	0.10251	-0.551080959	19.93394669	868.56657	5.7407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	231	chr7	87760688	chr7:87760688	T	TGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG,TGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG	56	PASS	AN=2;DP=231	GT	0/1
chr7	91700154	91700154	-	A	intronic	AKAP9	.	.	.	2.29E-05	0.999977065	4.21E-21	DISEASE: Long QT syndrome 11 (LQT11) [MIM:611820]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:18093912}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14649	0.1106	0.223857359	68.44774711	6014.5693	16.20152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	159	chr7	91700153	chr7:91700153	CA	CAA,C	52	PASS	AN=2;DP=159	GT	0/1
chr7	91700154	91700154	A	-	intronic	AKAP9	.	.	.	2.29E-05	0.999977065	4.21E-21	DISEASE: Long QT syndrome 11 (LQT11) [MIM:611820]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:18093912}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14649	0.1106	0.223857359	68.44774711	6014.5693	16.20152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	159	chr7	91700153	chr7:91700153	CA	CAA,C	52	PASS	AN=2;DP=159	GT	0/1
chr7	99752404	99752404	-	C	UTR3	C7orf43	NM_001303470:c.*229_*230insG;NM_018275:c.*229_*230insG	.	.	0.300413007	0.698742758	0.000844235	.	0.17356	0.1079	-0.53631094	20.53550366	39.8756	1.17381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	267	chr7	99752404	chr7:99752404	G	GC	75	PASS	AN=2;DP=267	GT	0/1
chr7	100460331	100460331	G	A	exonic	SLC12A9	.	synonymous SNV	SLC12A9:NM_001267814:exon11:c.G1473A:p.P491P,SLC12A9:NM_001267812:exon13:c.G1740A:p.P580P,SLC12A9:NM_020246:exon13:c.G1740A:p.P580P	2.37E-06	0.976967908	0.02302972	.	0.23194	0.15806	-1.168429872	6.062750649	76.20765	1.82962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	192	chr7	100460331	chr7:100460331	G	A	90	PASS	AN=2;DP=192	GT	0/1
chr7	102912324	102912324	A	-	ncRNA_intronic	DPY19L2P2	.	.	.	.	.	.	.	0.13982	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	97	chr7	102912323	chr7:102912323	TA	T	53	PASS	AN=2;DP=97	GT	0/1
chr7	116165017	116165017	T	-	UTR5	CAV1	NM_001753:c.-100del-	.	.	0.018707972	0.730737613	0.250554415	DISEASE: Congenital generalized lipodystrophy 3 (CGL3) [MIM:612526]: An autosomal recessive disorder characterized by a near complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. {ECO:0000269|PubMed:18211975}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pulmonary hypertension, primary, 3 (PPH3) [MIM:615343]: A rare disorder characterized by plexiform lesions of proliferating endothelial cells in pulmonary arterioles. The lesions lead to elevated pulmonary arterial pression, right ventricular failure, and death. The disease can occur from infancy throughout life and it has a mean age at onset of 36 years. Penetrance is reduced. Although familial pulmonary hypertension is rare, cases secondary to known etiologies are more common and include those associated with the appetite-suppressant drugs. {ECO:0000269|PubMed:22474227}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome (LCCNS) [MIM:606721]: A form of familial partial lipodystrophy associated with congenital cataracts and neurodegeneration leading to cerebellar and spinal cord dysfunction. {ECO:0000269|PubMed:18237401}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.48727	0.86293	-0.317668748	31.45789101	11.5877	0.41881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	801	chr7	116165016	chr7:116165016	CT	C	91	PASS	AN=2;DP=801	GT	0/1
chr7	122194609	122194609	A	G	exonic	CADPS2	.	synonymous SNV	CADPS2:NM_001009571:exon8:c.T1470C:p.H490H,CADPS2:NM_001167940:exon8:c.T1470C:p.H490H,CADPS2:NM_017954:exon8:c.T1470C:p.H490H	0.997778954	0.002221046	5.08E-12	.	0.45062	0.12261	-0.661316159	16.02382637	194.52292	3.0232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	222	chr7	122194609	chr7:122194609	A	G	149	PASS	AN=2;DP=222	GT	0/1
chr7	134221826	134221826	A	G	exonic	AKR1B10	.	synonymous SNV	AKR1B10:NM_020299:exon6:c.A576G:p.T192T	1.22E-05	0.600013778	0.399974041	.	0.15356	0.31956	0.374860183	75.43052607	369.36028	4.06189	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	298	chr7	134221826	chr7:134221826	A	G	112	PASS	AN=2;DP=298	GT	0/1
chr7	148106477	148106477	C	G	intronic	CNTNAP2	.	.	.	3.83E-05	0.99995799	3.72E-06	DISEASE: Autism 15 (AUTS15) [MIM:612100]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving CNTNAP2 is found in a patient with autism spectrum disorder. Paracentric inversion 46,XY,inv(7)(q11.22;q35). The inversion breakpoints disrupt the genes AUTS2 and CNTNAP2.; 	0.59066	0.10874	-2.24910054	1.29747582	193.23796	3.0143	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	269	chr7	148106477	chr7:148106477	C	G	149	PASS	AN=2;DP=269	GT	0/1
chr7	148106490	148106490	G	A	exonic	CNTNAP2	.	synonymous SNV	CNTNAP2:NM_014141:exon23:c.G3723A:p.A1241A	3.83E-05	0.99995799	3.72E-06	DISEASE: Autism 15 (AUTS15) [MIM:612100]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving CNTNAP2 is found in a patient with autism spectrum disorder. Paracentric inversion 46,XY,inv(7)(q11.22;q35). The inversion breakpoints disrupt the genes AUTS2 and CNTNAP2.; 	0.59066	0.10874	-2.24910054	1.29747582	193.23796	3.0143	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	266	chr7	148106490	chr7:148106490	G	A	145	PASS	AN=2;DP=266	GT	0/1
chr7	148516251	148516251	-	A	intronic	EZH2	.	.	.	0.999990079	9.92E-06	1.39E-13	DISEASE: Weaver syndrome (WVS) [MIM:277590]: A syndrome of accelerated growth and osseous maturation, unusual craniofacial appearance, hoarse and low-pitched cry, and hypertonia with camptodactyly. Distinguishing features of Weaver syndrome include broad forehead and face, ocular hypertelorism, prominent wide philtrum, micrognathia, deep horizontal chin groove, and deep-set nails. In addition, carpal bone development is advanced over the rest of the hand. {ECO:0000269|PubMed:22177091}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.97537	0.31462	-0.53631094	20.53550366	732.50896	5.37129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.97	230	chr7	148516251	chr7:148516251	T	TA	10.97	PASS	AN=0;DP=230	GT	0/1
chr7	155532574	155532576	CAC	-	exonic	RBM33	.	nonframeshift deletion	RBM33:NM_053043:exon12:c.1903_1905del:p.H641del	0.999967325	3.27E-05	5.14E-13	.	0.15099	.	-1.144569759	6.363529134	1720.69538	7.64985	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	291	chr7	155532573	chr7:155532573	GCAC	G	122	PASS	AN=2;DP=291	GT	0/1
chr8	26513709	26513709	A	T	UTR3	DPYSL2	NM_001197293:c.*487A>T;NM_001386:c.*487A>T;NM_001244604:c.*487A>T	.	.	0.995558289	0.00444163	8.13E-08	.	0.54792	0.54626	-0.756778259	13.44656759	125.03577	2.43271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	147	chr8	26513709	chr8:26513709	A	T	61	PASS	AN=2;DP=147	GT	0/1
chr8	39128387	39128387	C	-	intronic	ADAM32	.	.	.	1.17E-08	0.929586072	0.070413916	.	0.05738	0.07564	0.380318343	75.63104506	768.55107	5.48756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	245	chr8	39128386	chr8:39128386	TC	T	71	PASS	AN=2;DP=245	GT	0/1
chr8	52732287	52732287	C	T	UTR3	PCMTD1	NM_052937:c.*624G>A;NM_001286783:c.*624G>A;NM_001286782:c.*624G>A	.	.	2.56E-06	0.503470629	0.496526814	.	.	0.10723	0.169169615	65.33380514	3481.72932	11.35685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	181	chr8	52732287	chr8:52732287	C	T	80	PASS	AN=2;DP=181	GT	0/1
chr8	53596199	53596199	C	T	exonic	RB1CC1	.	synonymous SNV	RB1CC1:NM_001083617:exon5:c.G279A:p.S93S,RB1CC1:NM_014781:exon5:c.G279A:p.S93S	0.999999799	2.01E-07	4.29E-19	.	0.82038	0.21518	-1.587406381	3.113941967	234.10831	3.30711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	252	chr8	53596199	chr8:53596199	C	T	63	PASS	AN=2;DP=252	GT	0/1
chr8	62555483	62555483	-	A	intronic	ASPH	.	.	.	1.02E-08	0.995846118	0.004153872	.	0.0978	0.18131	-1.236390924	5.520169851	189.544	2.98859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	220	chr8	62555482	chr8:62555482	GA	GAA,G	74	PASS	AN=2;DP=220	GT	0/1
chr8	62555483	62555483	A	-	intronic	ASPH	.	.	.	1.02E-08	0.995846118	0.004153872	.	0.0978	0.18131	-1.236390924	5.520169851	189.544	2.98859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	220	chr8	62555482	chr8:62555482	GA	GAA,G	74	PASS	AN=2;DP=220	GT	0/1
chr8	89051473	89051473	-	T	UTR3	MMP16	NM_005941:c.*2215_*2216insA	.	.	0.916974084	0.083021227	4.69E-06	.	0.21595	0.19444	-0.381986487	27.68931352	33.08522	1.02452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	134	chr8	89051473	chr8:89051473	G	GT	62	PASS	AN=2;DP=134	GT	0/1
chr8	120114575	120114575	-	T	intronic	COLEC10	.	.	.	0.098536735	0.866536224	0.034927041	.	0.26958	0.13784	-0.115612493	45.12856806	56.82362	1.5176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	319	chr8	120114575	chr8:120114575	G	GT	74	PASS	AN=2;DP=319	GT	0/1
chr8	128429315	128429315	T	A	ncRNA_intronic	CASC8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	185	chr8	128429315	chr8:128429315	T	A	113	PASS	AN=2;DP=185	GT	0/1
chr8	144940706	144940706	C	T	exonic	EPPK1	.	nonsynonymous SNV	EPPK1:NM_031308:exon2:c.G6716A:p.R2239H	4.95E-21	0.001368596	0.998631404	.	.	.	.	.	5706.98129	15.64597	.	.	.	0.822	0.438	P	0.112	0.300	B	.	.	.	0.987	0.246	N	1.435	0.361	L	.	.	.	.	.	.	0.226	0.315	-0.897	0.483	T	0.164	0.501	T	.	.	.	5.942	0.816	27.6	0.997	0.809	0.275	0.231	N	c	-0.075	-0.050	1.000	0.747	0.716	0.820	0	3.7	0.414	-0.330	0.079	0.739	0.307	0.000	0.063	0.926	0.400	5.481	0.159	.	.	.	0.5	103	216	chr8	144940706	chr8:144940706	C	T	103	PASS	AN=2;DP=216	GT	0/1
chr8	145652340	145652340	-	G	UTR5	VPS28	NM_016208:c.-13_-12insC;NM_183057:c.-13_-12insC	.	.	0.115974874	0.857110731	0.026914395	.	0.20134	0.1297	-0.404032746	26.53338051	18.89106	0.65215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	525	chr8	145652340	chr8:145652340	T	TG	82	PASS	AN=2;DP=525	GT	0/1
chr9	73247	73247	C	T	ncRNA_intronic	PGM5P3-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	199	chr9	73247	chr9:73247	C	T	86	PASS	AN=2;DP=199	GT	0/1
chr9	215700	215700	A	T	UTR5	C9orf66	NM_152569:c.-304T>A	.	.	0.000775174	0.53508837	0.464136456	.	.	.	.	.	4564.52887	13.55817	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	150	chr9	215700	chr9:215700	A	T	118	PASS	AN=2;DP=150	GT	0/1
chr9	15433520	15433520	-	T	intronic	SNAPC3	.	.	.	5.54E-05	0.883341296	0.116603314	.	0.17643	0.10767	-0.069700724	48.54328851	386.09549	4.13838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	72	chr9	15433520	chr9:15433520	A	AT	82	PASS	AN=2;DP=72	GT	0/1
chr9	33469406	33469406	C	T	intronic	NOL6	.	.	.	0.999078032	0.000921968	2.94E-12	.	0.21138	0.11067	-0.231522913	36.36470866	535.96118	4.71978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	79	chr9	33469406	chr9:33469406	C	T	109	PASS	AN=2;DP=79	GT	0/1
chr9	66457628	66457628	G	A	ncRNA_intronic	LINC01410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	258	chr9	66457628	chr9:66457628	G	A	136	PASS	AN=2;DP=258	GT	0/1
chr9	69830318	69830318	G	A	intergenic	LOC101928381;FOXD4L5	dist=72534;dist=345389	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	300	chr9	69830318	chr9:69830318	G	A	109	PASS	AN=2;DP=300	GT	0/1
chr9	86276863	86276863	-	A	intronic	UBQLN1	.	.	.	0.998753262	0.00124672	1.81E-08	.	0.49245	0.31063	-0.314027422	31.9297004	45.11361	1.28969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	127	chr9	86276863	chr9:86276863	G	GA	62	PASS	AN=2;DP=127	GT	0/1
chr9	96259884	96259884	A	-	intronic	FAM120A	.	.	.	0.99990705	9.29E-05	6.56E-12	.	0.24853	0.11006	-2.037519759	1.657230479	38.57086	1.14394	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	179	chr9	96259883	chr9:96259883	TA	T	81	PASS	AN=2;DP=179	GT	0/1
chr9	116155669	116155669	-	CCCCAA	intronic	ALAD	.	.	.	0.06295026	0.933785175	0.003264564	DISEASE: Acute hepatic porphyria (AHEPP) [MIM:612740]: A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. AHP is characterized by attacks of gastrointestinal disturbances, abdominal colic, paralyses and peripheral neuropathy. Most attacks are precipitated by drugs, alcohol, caloric deprivation, infections, or endocrine factors. {ECO:0000269|PubMed:10706561, ECO:0000269|PubMed:1309003, ECO:0000269|PubMed:1569184, ECO:0000269|PubMed:2063868}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11936	0.55928	-0.558357437	19.54470394	471.54569	4.49402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	146	92	chr9	116155669	chr9:116155669	T	TCCCCAA	146	PASS	AN=2;DP=92	GT	0/1
chr9	118228115	118228115	-	G	intergenic	DEC1;LOC101928775	dist=63192;dist=273834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	81	chr9	118228115	chr9:118228115	A	AG	159	PASS	AN=2;DP=81	GT	0/1
chr9	139839920	139839920	G	-	intronic	C8G	.	.	.	1.63E-09	0.032163822	0.967836176	.	0.04668	.	0.196671391	67.19155461	801.2629	5.57646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	583	chr9	139839919	chr9:139839919	TG	T	87	PASS	AN=2;DP=583	GT	0/1
chr10	35360310	35360310	G	A	intronic	CUL2	.	.	.	0.99999841	1.59E-06	1.61E-15	.	0.72401	0.19444	-0.580403979	18.58928993	30.29769	0.96644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	143	chr10	35360310	chr10:35360310	G	A	78	PASS	AN=2;DP=143	GT	0/1
chr10	43694491	43694491	G	-	intronic	RASGEF1A	.	.	.	0.910096302	0.089875281	2.84E-05	.	0.28193	0.10809	0.084621747	60.31493277	52.5675	1.43524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	303	chr10	43694490	chr10:43694490	CG	C	67	PASS	AN=2;DP=303	GT	0/1
chr10	46195598	46195598	G	A	intergenic	ZFAND4;WASHC2C	dist=27337;dist=27050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	1109	chr10	46195598	chr10:46195598	G	A	101	PASS	AN=2;DP=1109	GT	0/1
chr10	51295198	51295198	A	C	ncRNA_intronic	PARGP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	48	15	chr10	51295198	chr10:51295198	A	C	48	PASS	AN=2;DP=15	GT	0/1
chr10	88834260	88834260	T	A	intronic	GLUD1	.	.	.	0.013935465	0.979595034	0.006469501	DISEASE: Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]: Familial hyperinsulinemic hypoglycemia [MIM:256450], also referred to as congenital hyperinsulinism, nesidioblastosis, or persistent hyperinsulinemic hypoglycemia of infancy (PPHI), is the most common cause of persistent hypoglycemia in infancy and is due to defective negative feedback regulation of insulin secretion by low glucose levels. In HHF6 elevated oxidation rate of glutamate to alpha-ketoglutarate stimulates insulin secretion in the pancreatic beta cells, while they impair detoxification of ammonium in the liver. {ECO:0000269|PubMed:10636977, ECO:0000269|PubMed:11214910, ECO:0000269|PubMed:11297618, ECO:0000269|PubMed:9571255}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.45386	0.70938	-0.029247611	51.40363293	74.75678	1.80903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	103	chr10	88834260	chr10:88834260	T	A	61	PASS	AN=2;DP=103	GT	0/1
chr10	88966676	88966676	-	T	intergenic	FAM35A;NUTM2A	dist=15436;dist=18529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	63	chr10	88966676	chr10:88966676	A	AT	55	PASS	AN=2;DP=63	GT	0/1
chr10	95099844	95099844	-	A	intronic	MYOF	.	.	.	2.08E-36	0.259659118	0.740340882	.	0.19502	0.13376	-0.435697896	24.68152866	2094.22471	8.43082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	212	chr10	95099844	chr10:95099844	G	GA	76	PASS	AN=2;DP=212	GT	0/1
chr10	95107509	95107509	G	A	exonic	MYOF	.	nonsynonymous SNV	MYOF:NM_133337:exon36:c.C4075T:p.P1359S,MYOF:NM_013451:exon37:c.C4114T:p.P1372S	2.08E-36	0.259659118	0.740340882	.	0.19502	0.13376	-0.435697896	24.68152866	2094.22471	8.43082	0.056	0.381	T	0.831	0.441	P	0.559	0.477	P	0.000	0.629	D	1.000	0.588	D	1.785	0.466	L	-0.24	0.668	T	-6.87	0.932	D	0.204	0.287	-0.393	0.723	T	0.327	0.696	T	0.023	0.460	T	3.151	0.438	22.6	0.999	0.959	0.976	0.759	D	c	0.437	0.418	1.000	0.747	0.722	0.854	0	5.68	0.880	7.847	0.851	1.048	0.713	1.000	0.715	0.978	0.483	10.822	0.456	C2 domain	.	.	0.5	84	316	chr10	95107509	chr10:95107509	G	A	84	PASS	AN=2;DP=316	GT	0/1
chr10	95107517	95107517	T	A	exonic	MYOF	.	nonsynonymous SNV	MYOF:NM_133337:exon36:c.A4067T:p.Y1356F,MYOF:NM_013451:exon37:c.A4106T:p.Y1369F	2.08E-36	0.259659118	0.740340882	.	0.19502	0.13376	-0.435697896	24.68152866	2094.22471	8.43082	0.001	0.784	D	1.0	0.899	D	0.999	0.916	D	0.000	0.629	N	1.000	0.588	D	2.61	0.766	M	-2.17	0.866	D	-3.68	0.703	D	0.428	0.486	0.667	0.928	D	0.782	0.926	D	0.060	0.679	D	4.475	0.599	24.2	0.983	0.393	0.985	0.835	D	c	0.412	0.329	1.000	0.747	0.722	0.854	0	4.53	0.548	8.017	0.886	1.061	0.807	1.000	0.715	0.996	0.625	12.109	0.529	C2 domain	.	.	0.5	76	304	chr10	95107517	chr10:95107517	T	A	76	PASS	AN=2;DP=304	GT	0/1
chr10	101959818	101959818	T	C	intronic	CHUK	.	.	.	0.998703705	0.001296295	1.65E-10	DISEASE: Cocoon syndrome (COCOS) [MIM:613630]: A lethal syndrome characterized by multiple fetal malformations including defective face and seemingly absent limbs, which are bound to the trunk and encased under the skin. {ECO:0000269|PubMed:20961246}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.84106	0.63405	-0.201976964	38.98325077	135.45191	2.53221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	65	chr10	101959818	chr10:101959818	T	C	122	PASS	AN=2;DP=65	GT	1/0
chr10	119764587	119764587	C	A	UTR3	RAB11FIP2	NM_014904:c.*3922G>T;NM_001330167:c.*3922G>T	.	.	0.910707841	0.089154579	0.000137579	.	0.32279	0.13177	0.086440867	60.47416844	470.93745	4.49152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	89	chr10	119764587	chr10:119764587	C	A	113	PASS	AN=2;DP=89	GT	1/0
chr10	126650990	126650990	T	-	intronic	ZRANB1	.	.	.	0.99983985	0.00016015	1.22E-10	.	0.15947	0.12378	-0.247889024	35.98726115	305.44181	3.72142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	116	chr10	126650989	chr10:126650989	CT	C	77	PASS	AN=2;DP=116	GT	0/1
chr10	127789605	127789605	-	T	intronic	ADAM12	.	.	.	0.341608447	0.658390535	1.02E-06	.	0.65368	0.23183	0.009173042	54.15782024	245.04565	3.37758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	184	chr10	127789605	chr10:127789605	C	CT	64	PASS	AN=2;DP=184	GT	0/1
chr11	373419	373419	-	CCGCCA	intronic	B4GALNT4	.	.	.	0.816930491	0.183069195	3.15E-07	.	0.13468	0.09235	.	.	1517.92316	7.2418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	280	chr11	373419	chr11:373419	C	CCCGCCA	67	PASS	AN=2;DP=280	GT	0/1
chr11	373427	373427	C	T	intronic	B4GALNT4	.	.	.	0.816930491	0.183069195	3.15E-07	.	0.13468	0.09235	.	.	1517.92316	7.2418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	295	chr11	373427	chr11:373427	C	T	101	PASS	AN=2;DP=295	GT	0/1
chr11	9459831	9459831	C	T	exonic	IPO7	.	synonymous SNV	IPO7:NM_006391:exon22:c.C2694T:p.T898T	0.999998375	1.63E-06	3.44E-16	.	0.84877	0.28646	-0.712684326	14.49634348	29.04313	0.92887	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	137	chr11	9459831	chr11:9459831	C	T	93	PASS	AN=2;DP=137	GT	0/1
chr11	18600278	18600278	G	A	exonic	UEVLD	.	synonymous SNV	UEVLD:NM_001040697:exon2:c.C120T:p.D40D,UEVLD:NM_001261382:exon2:c.C120T:p.D40D,UEVLD:NM_001261383:exon2:c.C120T:p.D40D,UEVLD:NM_001261385:exon2:c.C6T:p.D2D,UEVLD:NM_001261386:exon2:c.C120T:p.D40D,UEVLD:NM_001297771:exon2:c.C120T:p.D40D,UEVLD:NM_018314:exon2:c.C120T:p.D40D	1.09E-07	0.542920198	0.457079693	.	0.13244	0.14875	-0.402212257	26.7338995	286.11158	3.6211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	67	chr11	18600278	chr11:18600278	G	A	101	PASS	AN=2;DP=67	GT	1/0
chr11	46568662	46568662	C	T	splicing	AMBRA1	NM_001300731:exon4:c.378+1G>A;NM_017749:exon4:c.378+1G>A;NM_001267783:exon4:c.378+1G>A;NM_001267782:exon4:c.378+1G>A	.	.	0.999971641	2.84E-05	7.36E-14	.	0.36907	0.10363	-0.971800989	8.946685539	137.80881	2.55655	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.896	0.809	27.5	0.994	0.619	0.986	0.841	D	c	1.147	1.006	1.000	0.747	0.156	0.027	0	5.68	0.880	5.632	0.673	0.007	0.138	1.000	0.715	0.993	0.574	19.789	0.964	.	.	.	0.5	42	85	chr11	46568662	chr11:46568662	C	T	42	PASS	AN=2;DP=85	GT	0/1
chr11	47204533	47204533	C	-	intronic	PACSIN3	.	.	.	0.016793048	0.978273746	0.004933206	.	0.49122	0.20173	-0.532670911	20.78320359	1052.93556	6.23032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	333	chr11	47204532	chr11:47204532	TC	T	66	PASS	AN=2;DP=333	GT	0/1
chr11	49729300	49729300	C	-	ncRNA_intronic	LOC440040	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	47	chr11	49729299	chr11:49729299	AC	A	98	PASS	AN=2;DP=47	GT	0/1
chr11	55579182	55579182	A	G	exonic	OR5L1	.	synonymous SNV	OR5L1:NM_001004738:exon1:c.A240G:p.K80K	5.94E-07	0.039026869	0.960972537	.	0.06073	0.09152	0.795569043	87.49115357	1193.77829	6.55439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	184	chr11	55579182	chr11:55579182	A	G	109	PASS	AN=2;DP=184	GT	0/1
chr11	60666409	60666409	-	A	intronic	PRPF19	.	.	.	0.998566696	0.001433279	2.54E-08	.	0.60527	0.17956	-0.560178693	19.30879925	12.11009	0.43916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	220	chr11	60666409	chr11:60666409	G	GA	69	PASS	AN=2;DP=220	GT	0/1
chr11	62295897	62295897	G	A	exonic	AHNAK	.	synonymous SNV	AHNAK:NM_001346445:exon5:c.C5992T:p.L1998L,AHNAK:NM_001346446:exon5:c.C5992T:p.L1998L,AHNAK:NM_001620:exon5:c.C5992T:p.L1998L	0.344567387	0.655432572	4.07E-08	.	0.19089	.	-2.834287974	0.613352206	5147.67106	14.73759	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	356	chr11	62295897	chr11:62295897	G	A	78	PASS	AN=2;DP=356	GT	0/1
chr11	66278427	66278427	-	T	intronic	BBS1	.	.	.	1.78E-07	0.962498134	0.037501688	DISEASE: Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:12118255, ECO:0000269|PubMed:12524598, ECO:0000269|PubMed:12567324, ECO:0000269|PubMed:12677556, ECO:0000269|PubMed:12920096, ECO:0000269|PubMed:15770229, ECO:0000269|PubMed:21052717, ECO:0000269|PubMed:21344540}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	-0.264476624	34.8844067	2.96492	0.10746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	220	chr11	66278427	chr11:66278427	G	GT	78	PASS	AN=2;DP=220	GT	0/1
chr11	72549649	72549649	-	A	UTR3	FCHSD2	NM_014824:c.*186_*187insT	.	.	0.994752587	0.005247408	5.00E-09	.	0.39961	0.11323	-0.88906181	10.36801132	103.87407	2.20142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	177	chr11	72549649	chr11:72549649	C	CA	75	PASS	AN=2;DP=177	GT	0/1
chr11	77639466	77639466	A	G	exonic	INTS4	.	synonymous SNV	INTS4:NM_033547:exon11:c.T1293C:p.S431S	0.653071264	0.346928651	8.43E-08	.	0.16947	0.15282	-0.576764155	18.7839113	270.96358	3.52905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	66	chr11	77639466	chr11:77639466	A	G	127	PASS	AN=2;DP=66	GT	0/1
chr11	117045616	117045616	T	C	UTR3	PAFAH1B2	NM_001184748:c.*2T>C	.	.	0.962029472	0.037892339	7.82E-05	.	0.65851	0.15588	-0.075159878	47.78839349	4.02051	0.14794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	75	chr11	117045616	chr11:117045616	T	C	71	PASS	AN=2;DP=75	GT	0/1
chr11	124015941	124015941	C	T	intronic	VWA5A	.	.	.	1.89E-15	0.026741774	0.973258226	.	0.04851	.	0.648517637	84.14720453	1165.38867	6.49454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	143	chr11	124015941	chr11:124015941	C	T	121	PASS	AN=2;DP=143	GT	0/1
chr11	124096173	124096173	T	C	exonic	OR8G2P	.	nonsynonymous SNV	OR8G2P:NM_001291438:exon1:c.T776C:p.L259S	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	176	chr11	124096173	chr11:124096173	T	C	84	PASS	AN=2;DP=176	GT	0/1
chr11	124951304	124951304	-	T	intronic	SLC37A2	.	.	.	5.01E-10	0.581719585	0.418280414	.	0.10703	0.11611	0.04598748	57.47817882	1459.43023	7.12342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	296	chr11	124951303	chr11:124951303	AT	ATT,A	72	PASS	AN=2;DP=296	GT	0/1
chr11	124951304	124951304	T	-	intronic	SLC37A2	.	.	.	5.01E-10	0.581719585	0.418280414	.	0.10703	0.11611	0.04598748	57.47817882	1459.43023	7.12342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	296	chr11	124951303	chr11:124951303	AT	ATT,A	72	PASS	AN=2;DP=296	GT	0/1
chr11	125505377	125505377	-	A	exonic	CHEK1	.	frameshift insertion	CHEK1:NM_001330427:exon6:c.716dupA:p.T242Nfs*18,CHEK1:NM_001330428:exon6:c.386dupA:p.T132Nfs*18,CHEK1:NM_001114121:exon7:c.668dupA:p.T226Nfs*18,CHEK1:NM_001114122:exon7:c.668dupA:p.T226Nfs*18,CHEK1:NM_001244846:exon7:c.668dupA:p.T226Nfs*18,CHEK1:NM_001274:exon7:c.668dupA:p.T226Nfs*18	0.00024911	0.982312119	0.017438771	.	0.99413	0.5268	-0.315847836	31.68789809	581.70191	4.88824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	247	chr11	125505377	chr11:125505377	G	GA	75	PASS	AN=2;DP=247	GT	0/1
chr12	5603607	5603607	G	A	exonic	NTF3	.	nonsynonymous SNV	NTF3:NM_002527:exon1:c.G227A:p.G76E,NTF3:NM_001102654:exon2:c.G266A:p.G89E	0.854440385	0.145066088	0.000493527	.	0.35201	0.52992	-0.073340031	48.11866006	726.21579	5.34917	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.018	0.276	N	1	0.090	P	-1.885	0.002	N	1.1	0.390	T	0.61	0.025	N	0.017	0.012	-1.022	0.230	T	0.000	0.000	T	.	.	.	-0.365	0.064	0.470	0.473	0.038	0.049	0.106	N	c	-1.009	-0.768	1.000	0.454	0.554	0.283	0	4.84	0.620	1.883	0.391	0.202	0.252	0.946	0.326	0.227	0.223	9.911	0.404	.	.	.	0.5	158	507	chr12	5603607	chr12:5603607	G	A	158	PASS	AN=2;DP=507	GT	0/1
chr12	8287231	8287231	T	C	ncRNA_exonic	POU5F1P3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	950	chr12	8287231	chr12:8287231	T	C	84	PASS	AN=2;DP=950	GT	0/1
chr12	25361440	25361440	A	-	UTR3	KRAS	NM_033360:c.*1410delT;NM_004985:c.*1289delT	.	.	0.001061193	0.603148256	0.395790551	DISEASE: Leukemia, acute myelogenous (AML) [MIM:601626]: A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes. {ECO:0000269|PubMed:8955068}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. {ECO:0000269|PubMed:17332249}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Noonan syndrome 3 (NS3) [MIM:609942]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. {ECO:0000269|PubMed:16474405, ECO:0000269|PubMed:16773572, ECO:0000269|PubMed:17056636, ECO:0000269|PubMed:17468812, ECO:0000269|PubMed:19396835}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. {ECO:0000269|PubMed:14534542, ECO:0000269|PubMed:3034404, ECO:0000269|PubMed:7773929}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in KRAS are a cause of pylocytic astrocytoma (PA). Pylocytic astrocytomas are neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. {ECO:0000269|PubMed:16247081}.; DISEASE: Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278]: A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. CFC2 patients often do not have the skin abnormalities, such as ichthyosis, hyperkeratosis, and hemangioma observed in CFC1. {ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:16474405, ECO:0000269|PubMed:17056636, ECO:0000269|PubMed:21797849}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=KRAS mutations are involved in cancer development. {ECO:0000269|PubMed:14534542, ECO:0000269|PubMed:1553789, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:3034404, ECO:0000269|PubMed:3627975, ECO:0000269|PubMed:6092920, ECO:0000269|PubMed:6695174, ECO:0000269|PubMed:7773929}.; 	0.99997	0.53296	-0.141298762	42.87567823	3.46519	0.12617	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	454	chr12	25361439	chr12:25361439	TA	T	74	PASS	AN=2;DP=454	GT	0/1
chr12	26834804	26834804	-	ACTC	intronic	ITPR2	.	.	.	5.74E-11	1	2.30E-12	DISEASE: Anhidrosis, isolated, with normal sweat glands (ANHD) [MIM:106190]: An autosomal recessive disorder characterized by generalized, isolated anhidrosis, severe heat intolerance, and morphologically normal eccrine sweat glands. Body growth, teeth, hair, nails, and skin are normal. {ECO:0000269|PubMed:25329695}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.90112	0.20622	-1.641009998	2.777777778	698.25496	5.25954	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	82	chr12	26834804	chr12:26834804	T	TACTC	90	PASS	AN=2;DP=82	GT	0/1
chr12	27461257	27461257	-	T	intronic	STK38L	.	.	.	0.965893632	0.034103905	2.46E-06	.	0.72805	0.12607	-0.361761279	28.6329323	9.52509	0.35064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	307	chr12	27461257	chr12:27461257	G	GT	84	PASS	AN=2;DP=307	GT	0/1
chr12	48174043	48174043	C	T	exonic	SLC48A1	.	synonymous SNV	SLC48A1:NM_017842:exon3:c.C420T:p.I140I	0.437511991	0.457729968	0.104758041	.	.	.	.	.	3.1238	0.11179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	219	chr12	48174043	chr12:48174043	C	T	52	PASS	AN=2;DP=219	GT	0/1
chr12	50026779	50026779	-	C	intronic	PRPF40B	.	.	.	0.988653394	0.011346606	2.74E-10	.	0.46946	0.08281	-1.460519861	3.809860816	70.83292	1.75248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	285	chr12	50026779	chr12:50026779	G	GC	85	PASS	AN=2;DP=285	GT	0/1
chr12	51796890	51796941	TTAGGTAATAGGTATAAACTGCTCAGAACAGTGCTCAGAACATAATAAATGC	-	intronic	SLC4A8	.	.	.	0.999867374	0.000132626	6.38E-13	.	0.07064	0.11699	-0.799052816	12.45576787	53.47821	1.45321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	53	chr12	51796889	chr12:51796889	ATTAGGTAATAGGTATAAACTGCTCAGAACAGTGCTCAGAACATAATAAATGC	A	133	PASS	AN=2;DP=53	GT	1/0
chr12	54676165	54676165	-	T	ncRNA_intronic	HNRNPA1P10	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	89	chr12	54676165	chr12:54676165	G	GT	64	PASS	AN=2;DP=89	GT	0/1
chr12	57522680	57522680	G	-	UTR5	LRP1	NM_002332:c.-68del-	.	.	1	1.45E-26	2.05E-66	.	0.65439	0.76644	-7.278555259	0.017692852	526.27186	4.68307	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	417	chr12	57522679	chr12:57522679	TG	T	84	PASS	AN=2;DP=417	GT	0/1
chr12	62799750	62799750	-	T	UTR3	USP15	NM_006313:c.*1595_*1596insT;NM_001252078:c.*1595_*1596insT;NM_001351166:c.*1595_*1596insT;NM_001351165:c.*1595_*1596insT;NM_001351164:c.*1595_*1596insT;NM_001351163:c.*1595_*1596insT;NM_001351159:c.*1595_*1596insT;NM_001351160:c.*1595_*1596insT	.	.	0.990365016	0.009634984	1.83E-10	.	0.80464	0.14896	-0.979072682	8.752064166	37.09012	1.10797	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	123	chr12	62799750	chr12:62799750	G	GT	64	PASS	AN=2;DP=123	GT	0/1
chr12	91340253	91340253	T	-	ncRNA_exonic	LINC00615	.	.	.	.	.	.	.	0.06168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	48	100	chr12	91340252	chr12:91340252	CT	C,CTT	48	PASS	AN=2;DP=100	GT	0/1
chr12	91340253	91340253	-	T	ncRNA_exonic	LINC00615	.	.	.	.	.	.	.	0.06168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	48	100	chr12	91340252	chr12:91340252	CT	C,CTT	48	PASS	AN=2;DP=100	GT	0/1
chr12	98989188	98989188	-	T	intronic	SLC25A3	.	.	.	0.071557649	0.915646572	0.012795779	DISEASE: Mitochondrial phosphate carrier deficiency (MPCD) [MIM:610773]: Fatal disorder of oxidative phosphorylation. Patients have lactic acidosis, hypertrophic cardiomyopathy and muscular hypotonia and die within the first year of life. {ECO:0000269|PubMed:17273968}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30153	0.22672	-0.626318434	17.03231894	20.64253	0.70171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	149	chr12	98989187	chr12:98989187	AT	ATT,A	64	PASS	AN=2;DP=149	GT	0/1
chr12	98989188	98989188	T	-	intronic	SLC25A3	.	.	.	0.071557649	0.915646572	0.012795779	DISEASE: Mitochondrial phosphate carrier deficiency (MPCD) [MIM:610773]: Fatal disorder of oxidative phosphorylation. Patients have lactic acidosis, hypertrophic cardiomyopathy and muscular hypotonia and die within the first year of life. {ECO:0000269|PubMed:17273968}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30153	0.22672	-0.626318434	17.03231894	20.64253	0.70171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	149	chr12	98989187	chr12:98989187	AT	ATT,A	64	PASS	AN=2;DP=149	GT	0/1
chr12	102140523	102140523	A	-	UTR3	GNPTAB	NM_024312:c.*419delT	.	.	4.23E-06	0.999977941	1.78E-05	DISEASE: Mucolipidosis type II (MLII) [MIM:252500]: Fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features, peculiar fibroblast inclusions, and no excessive mucopolysacchariduria. Congenital dislocation of the hip, thoracic deformities, hernia, and hyperplastic gums are evident soon after birth. {ECO:0000269|PubMed:16200072, ECO:0000269|PubMed:16835905, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:22495880, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:23733939, ECO:0000269|PubMed:23773965, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24798265, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]: Autosomal recessive disease of lysosomal enzyme targeting. Clinically MLIII is characterized by restricted joint mobility, skeletal dysplasia, and short stature. Mildly coarsened facial features and thickening of the skin have been described. Cardiac valvular disease and corneal clouding may also occur. Half of the reported patients show learning disabilities or mental retardation. {ECO:0000269|PubMed:16094673, ECO:0000269|PubMed:16465621, ECO:0000269|PubMed:16630736, ECO:0000269|PubMed:17034777, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:24045841, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24550498, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in GNPTAB have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech. {ECO:0000269|PubMed:20147709}.; 	0.70519	0.14868	-1.366884746	4.505779665	437.11196	4.35866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	115	chr12	102140522	chr12:102140522	GA	G	84	PASS	AN=2;DP=115	GT	0/1
chr12	102301162	102301162	-	T	intronic	DRAM1	.	.	.	0.080700077	0.872050796	0.047249127	.	.	.	-0.229483771	36.86010852	8.7844	0.32424	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	148	chr12	102301162	chr12:102301162	G	GT	70	PASS	AN=2;DP=148	GT	0/1
chr12	108913292	108913292	-	A	UTR3	FICD	NM_007076:c.*40_*41insA	.	.	0.006385822	0.74494476	0.248669418	.	0.16362	0.11879	-0.841329384	11.36470866	77.87832	1.86121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.33	91	chr12	108913292	chr12:108913292	G	GA	14.33	PASS	AN=0;DP=91	GT	0/1
chr12	108913381	108913382	TA	-	downstream	FICD	dist=1	.	.	0.006385822	0.74494476	0.248669418	.	0.16362	0.11879	-0.841329384	11.36470866	77.87832	1.86121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.06	89	chr12	108913380	chr12:108913380	TTA	T	10.06	PASS	AN=0;DP=89	GT	0/1
chr12	116397416	116397416	C	T	UTR3	MED13L	NM_015335:c.*1655G>A	.	.	0.999999999	1.32E-09	2.08E-24	DISEASE: Note=A chromosomal aberration involving MED13L is found in a patient with transposition of the great arteries, dextro- looped and mental retardation. Translocation t(12;17)(q24.1;q21). {ECO:0000269|PubMed:14638541}.; 	0.80264	0.11567	-2.736273894	0.690021231	206.98599	3.10912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	51	chr12	116397416	chr12:116397416	C	T	81	PASS	AN=2;DP=51	GT	0/1
chr12	121764972	121764972	G	A	exonic	ANAPC5	.	nonsynonymous SNV	ANAPC5:NM_001137559:exon11:c.C1031T:p.A344V,ANAPC5:NM_001330489:exon11:c.C1328T:p.A443V,ANAPC5:NM_016237:exon11:c.C1367T:p.A456V	4.18E-05	0.99800999	0.00194821	.	0.36079	.	-0.554717505	19.79830149	76.22212	1.8303	0.934	0.062	T	0.001	0.067	B	0.0	0.040	B	0.009	0.305	N	1	0.090	N	-0.69	0.019	N	.	.	.	-0.93	0.281	N	0.049	0.210	-1.036	0.184	T	0.037	0.158	T	0.002	0.028	T	0.866	0.177	9.865	0.337	0.020	0.728	0.353	D	c	-0.672	-0.474	0.998	0.359	0.707	0.730	0	4.04	0.461	4.701	0.613	0.143	0.228	0.990	0.367	0.602	0.289	4.584	0.116	Anaphase-promoting complex subunit 5|Tetratricopeptide-like helical domain;Tetratricopeptide-like helical domain	.	.	0.5	117	236	chr12	121764972	chr12:121764972	G	A	117	PASS	AN=2;DP=236	GT	0/1
chr12	123345086	123345086	-	G	intronic	HIP1R	.	.	.	1.44E-06	0.999915155	8.34E-05	.	0.26127	0.10468	-1.054560763	7.60202878	723.1398	5.33777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	166	chr12	123345086	chr12:123345086	T	TG	69	PASS	AN=2;DP=166	GT	0/1
chr12	123907659	123907659	T	C	exonic	RILPL2	.	synonymous SNV	RILPL2:NM_145058:exon3:c.A537G:p.K179K	0.060872187	0.868916205	0.070211608	.	0.07683	0.07466	-0.185391282	39.67916962	29.91633	0.9548	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	58	chr12	123907659	chr12:123907659	T	C	54	PASS	AN=2;DP=58	GT	0/1
chr13	19775753	19775753	G	A	intergenic	LOC101928697;ANKRD26P3	dist=14148;dist=61187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	82	chr13	19775753	chr13:19775753	G	A	88	PASS	AN=2;DP=82	GT	0/1
chr13	49796204	49796204	C	T	exonic	MLNR	.	synonymous SNV	MLNR:NM_001507:exon2:c.C930T:p.C310C	0.046587675	0.854459372	0.098952953	.	0.19209	0.11347	.	.	83.27787	1.93998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	174	chr13	49796204	chr13:49796204	C	T	44	PASS	AN=2;DP=174	GT	0/1
chr13	50570574	50570574	T	-	ncRNA_exonic	MIR3613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	139	chr13	50570573	chr13:50570573	CT	C	90	PASS	AN=2;DP=139	GT	0/1
chr13	53013249	53013249	C	T	exonic	VPS36	.	nonsynonymous SNV	VPS36:NM_001282168:exon3:c.G193A:p.A65T,VPS36:NM_001282169:exon3:c.G46A:p.A16T,VPS36:NM_016075:exon3:c.G220A:p.A74T	0.100608361	0.899084406	0.000307233	.	0.09703	0.1199	-0.295622497	32.61972163	29.0318	0.92832	0.382	0.111	T	0.07	0.224	B	0.034	0.212	B	0.000	0.629	D	1	0.810	D	1.405	0.356	L	.	.	.	-1.26	0.318	N	0.589	0.617	-0.907	0.472	T	0.175	0.519	T	0.004	0.107	T	3.780	0.511	23.4	0.989	0.484	0.990	0.898	D	c	0.033	0.236	1.000	0.747	0.706	0.609	0	5.38	0.772	6.964	0.757	0.935	0.490	1.000	0.715	0.998	0.697	18.492	0.908	PH domain-like|Vacuolar protein sorting protein 36, GLUE domain	.	.	0.5	42	72	chr13	53013249	chr13:53013249	C	T	42	PASS	AN=2;DP=72	GT	0/1
chr13	97484970	97484970	C	T	exonic	HS6ST3	.	nonsynonymous SNV	HS6ST3:NM_153456:exon2:c.C934T:p.R312C	0.747377573	0.250362514	0.002259914	.	0.59827	0.11479	-0.113792788	45.25831564	369.2782	4.06133	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.810	D	2.95	0.852	M	0.98	0.421	T	-7.37	0.947	D	0.973	0.974	-0.217	0.773	T	0.354	0.717	T	0.052	0.650	D	7.687	0.954	35	0.999	0.996	0.986	0.839	D	c	0.971	0.921	1.000	0.747	0.554	0.246	0	5.65	0.868	7.902	0.860	0.935	0.490	1.000	0.715	1.000	0.888	19.715	0.961	P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	58	186	chr13	97484970	chr13:97484970	C	T	58	PASS	AN=2;DP=186	GT	0/1
chr13	100635045	100635045	T	-	exonic	ZIC2	.	frameshift deletion	ZIC2:NM_007129:exon1:c.727delT:p.F244Sfs*12	.	.	.	DISEASE: Holoprosencephaly 5 (HPE5) [MIM:609637]: A structural anomaly of the brain, in which the developing forebrain fails to correctly separate into right and left hemispheres. Holoprosencephaly is genetically heterogeneous and associated with several distinct facies and phenotypic variability. {ECO:0000269|PubMed:11285244, ECO:0000269|PubMed:15221788, ECO:0000269|PubMed:19177455}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87813	0.23021	.	.	382.0785	4.12056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	304	chr13	100635044	chr13:100635044	CT	C	71	PASS	AN=2;DP=304	GT	0/1
chr14	23745310	23745310	A	-	exonic	HOMEZ	.	frameshift deletion	HOMEZ:NM_020834:exon2:c.1127delT:p.L376Yfs*13	0.342229012	0.654816905	0.002954083	.	0.12857	0.09376	0.286674996	71.49681529	4926.41666	14.30388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	279	chr14	23745309	chr14:23745309	TA	T	62	PASS	AN=2;DP=279	GT	0/1
chr14	31575373	31575373	-	A	intronic	HECTD1	.	.	.	1	2.36E-13	1.27E-35	.	0.71166	0.10385	-2.227040428	1.332861524	686.62409	5.23205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	198	chr14	31575373	chr14:31575373	T	TA	96	PASS	AN=2;DP=198	GT	0/1
chr14	50300780	50300780	-	T	intronic	NEMF	.	.	.	0.981706446	0.018293554	1.48E-12	.	0.95132	.	-1.703090605	2.535975466	82.89587	1.93339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	96	chr14	50300780	chr14:50300780	A	AT	102	PASS	AN=2;DP=96	GT	0/1
chr14	64669477	64669477	-	T	intronic	SYNE2	.	.	.	1.85E-11	1	3.59E-33	DISEASE: Emery-Dreifuss muscular dystrophy 5, autosomal dominant (EDMD5) [MIM:612999]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:17761684}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.21106	.	3.839142661	99.63434772	10907.00643	22.66019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	348	chr14	64669477	chr14:64669477	G	GT	82	PASS	AN=2;DP=348	GT	0/1
chr14	70714144	70714144	A	G	ncRNA_exonic	ADAM21P1	.	.	.	.	.	.	.	.	0.09205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	chr14	70714144	chr14:70714144	A	G	.	PASS	AN=0;DP=112	GT	0/1
chr14	72941317	72941317	-	T	intronic	RGS6	.	.	.	0.801361183	0.198636867	1.95E-06	.	0.44756	0.09798	-0.670411825	15.61689078	74.87042	1.81038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	233	chr14	72941317	chr14:72941317	G	GT	70	PASS	AN=2;DP=233	GT	0/1
chr14	74534275	74534275	-	A	intronic	ALDH6A1	.	.	.	1.62E-05	0.992502487	0.00748129	DISEASE: Methylmalonate semialdehyde dehydrogenase deficiency (MMSDHD) [MIM:614105]: A metabolic disorder characterized by elevated beta-alanine, 3-hydroxypropionic acid, and both isomers of 3-amino and 3-hydroxyisobutyric acids in urine organic acids. {ECO:0000269|PubMed:10947204}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20099	0.21694	-0.402212257	26.7338995	42.69019	1.23859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	160	chr14	74534274	chr14:74534274	TA	TAA,T	62	PASS	AN=2;DP=160	GT	0/1
chr14	74534275	74534275	A	-	intronic	ALDH6A1	.	.	.	1.62E-05	0.992502487	0.00748129	DISEASE: Methylmalonate semialdehyde dehydrogenase deficiency (MMSDHD) [MIM:614105]: A metabolic disorder characterized by elevated beta-alanine, 3-hydroxypropionic acid, and both isomers of 3-amino and 3-hydroxyisobutyric acids in urine organic acids. {ECO:0000269|PubMed:10947204}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20099	0.21694	-0.402212257	26.7338995	42.69019	1.23859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	160	chr14	74534274	chr14:74534274	TA	TAA,T	62	PASS	AN=2;DP=160	GT	0/1
chr14	80320317	80320317	-	T	intronic	NRXN3	.	.	.	0.999855501	0.000144499	1.92E-11	.	0.61924	0.11925	-1.548724932	3.273177636	47.34272	1.33505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	311	chr14	80320317	chr14:80320317	A	AT	82	PASS	AN=2;DP=311	GT	0/1
chr14	96788614	96788614	A	-	intronic	ATG2B	.	.	.	8.13E-05	0.999918726	1.75E-11	.	0.31648	.	0.486743222	79.3819297	1250.48072	6.67455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	171	chr14	96788613	chr14:96788613	CA	C,CAA	84	PASS	AN=2;DP=171	GT	0/1
chr14	96788614	96788614	-	A	intronic	ATG2B	.	.	.	8.13E-05	0.999918726	1.75E-11	.	0.31648	.	0.486743222	79.3819297	1250.48072	6.67455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	171	chr14	96788613	chr14:96788613	CA	C,CAA	84	PASS	AN=2;DP=171	GT	0/1
chr14	100947656	100947656	T	-	intronic	WDR25	.	.	.	0.04222611	0.951707462	0.006066428	.	0.17238	0.09554	0.270087468	70.69473933	325.26772	3.83376	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	324	chr14	100947655	chr14:100947655	CT	C	62	PASS	AN=2;DP=324	GT	0/1
chr14	105269409	105269409	G	-	UTR3	ZBTB42	NM_001137601:c.*606delG	.	.	.	.	.	.	.	.	0.768075923	86.8895966	146.30778	2.63567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	297	chr14	105269408	chr14:105269408	TG	T	127	PASS	AN=2;DP=297	GT	0/1
chr15	40384100	40384100	A	-	intronic	BMF	.	.	.	0.354021066	0.633166286	0.012812648	.	0.10921	0.1088	-0.229483771	36.86010852	9.98435	0.36607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	57	chr15	40384099	chr15:40384099	GA	G	103	PASS	AN=2;DP=57	GT	0/1
chr15	42144979	42144979	C	-	intronic	SPTBN5	.	.	.	1.09E-70	6.32E-11	1	.	0.16852	0.12091	.	.	13728.76893	25.43136	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	375	chr15	42144978	chr15:42144978	GC	G	97	PASS	AN=2;DP=375	GT	0/1
chr15	59912375	59912375	T	-	downstream	GCNT3	dist=165	.	.	4.04E-09	0.054399435	0.945600561	.	0.11221	0.09788	0.446457185	77.97829677	58.26865	1.54572	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	180	chr15	59912374	chr15:59912374	AT	A	65	PASS	AN=2;DP=180	GT	0/1
chr15	69072347	69072347	-	G	UTR3	ANP32A	NM_006305:c.*72_*73insC	.	.	0.973870036	0.026098984	3.10E-05	.	0.54777	0.25991	-0.075159878	47.78839349	4.49266	0.16267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	179	chr15	69072346	chr15:69072346	AG	AGG,A	54	PASS	AN=2;DP=179	GT	0/1
chr15	69072347	69072347	G	-	UTR3	ANP32A	NM_006305:c.*73delC	.	.	0.973870036	0.026098984	3.10E-05	.	0.54777	0.25991	-0.075159878	47.78839349	4.49266	0.16267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	179	chr15	69072346	chr15:69072346	AG	AGG,A	54	PASS	AN=2;DP=179	GT	0/1
chr15	78397503	78397503	-	T	UTR3	CIB2	NM_001301224:c.*149_*150insA;NM_001271889:c.*149_*150insA;NM_001271888:c.*149_*150insA;NM_006383:c.*149_*150insA	.	.	0.000468493	0.667683033	0.331848474	DISEASE: Usher syndrome 1J (USH1J) [MIM:614869]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness. {ECO:0000269|PubMed:23023331}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40943	0.13588	-0.293801652	32.93819297	57.97419	1.53939	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	138	chr15	78397503	chr15:78397503	G	GT	116	PASS	AN=2;DP=138	GT	0/1
chr15	82935129	82935129	C	G	exonic	GOLGA6L10	.	nonsynonymous SNV	GOLGA6L10:NM_001322400:exon6:c.G451C:p.E151Q	0.36895894	0.48046894	0.15057212	.	.	.	.	.	738.28141	5.39276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	410	chr15	82935129	chr15:82935129	C	G	83	PASS	AN=2;DP=410	GT	0/1
chr15	102287990	102287990	T	-	upstream	LOC100128108	dist=917	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	198	chr15	102287989	chr15:102287989	AT	A	71	PASS	AN=2;DP=198	GT	0/1
chr16	5037499	5037499	G	-	intronic	SEC14L5	.	.	.	6.57E-10	0.408296631	0.591703368	.	0.15183	.	-1.703090605	2.535975466	83.7768	1.94866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	118	chr16	5037498	chr16:5037498	TG	T	111	PASS	AN=2;DP=118	GT	0/1
chr16	7560323	7560323	-	T	intronic	RBFOX1	.	.	.	0.935961018	0.064036563	2.42E-06	.	.	.	-0.466531444	23.51380042	64.21028	1.64414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	181	chr16	7560323	chr16:7560323	G	GT	65	PASS	AN=2;DP=181	GT	0/1
chr16	14312764	14312764	C	T	exonic	MKL2	.	nonsynonymous SNV	MKL2:NM_001308142:exon8:c.C602T:p.A201V,MKL2:NM_014048:exon8:c.C602T:p.A201V	0.999938116	6.19E-05	2.44E-12	DISEASE: Note=A chromosomal aberration involving C11orf95 is found in 3 chondroid lipomas. Translocation t(11;16)(q13;p13) with C11orf95 produces a C11orf95-MKL2 fusion protein (PubMed:20607705). {ECO:0000269|PubMed:20607705}.; 	0.38756	0.08351	-1.548724932	3.273177636	106.48563	2.23956	0.011	0.555	D	0.951	0.899	P	0.242	0.690	B	0.000	0.559	D	1.000	0.548	D	2.075	0.572	M	-7.08	0.998	D	-3.46	0.677	D	0.334	0.507	0.996	0.971	D	0.991	0.998	D	0.715	0.977	D	5.691	0.776	26.8	0.999	0.961	0.980	0.790	D	c	0.387	0.418	1.000	0.747	0.651	0.465	0	5.52	0.821	3.951	0.561	0.935	0.490	0.998	0.411	0.375	0.250	18.471	0.907	.	.	.	0.5	69	338	chr16	14312764	chr16:14312764	C	T	69	PASS	AN=2;DP=338	GT	0/1
chr16	15474951	15474951	C	T	intergenic	NPIPA5;MPV17L	dist=2800;dist=14660	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	189	chr16	15474951	chr16:15474951	C	T	97	PASS	AN=2;DP=189	GT	0/1
chr16	19132593	19132593	-	A	UTR3	ITPRIPL2	NM_001034841:c.*5202_*5203insA	.	.	0.018503394	0.896702885	0.084793722	.	.	.	0.551232944	81.48148148	484.31785	4.52979	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	212	chr16	19132593	chr16:19132593	G	GA	81	PASS	AN=2;DP=212	GT	0/1
chr16	21823156	21823156	A	G	ncRNA_exonic	RRN3P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	43	chr16	21823156	chr16:21823156	A	G	105	PASS	AN=2;DP=43	GT	0/1
chr16	29113497	29113497	-	T	ncRNA_intronic	RRN3P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	149	chr16	29113497	chr16:29113497	A	AT	84	PASS	AN=2;DP=149	GT	0/1
chr16	57509698	57509699	CT	-	intronic	DOK4	.	.	.	0.19760291	0.792064709	0.010332382	.	0.55569	0.13588	-0.66859065	15.76433121	109.57389	2.27428	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	212	chr16	57509697	chr16:57509697	CCT	C	115	PASS	AN=2;DP=212	GT	0/1
chr16	70013125	70013125	G	A	ncRNA_intronic	PDXDC2P-NPIPB14P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	271	chr16	70013125	chr16:70013125	G	A	.	PASS	AN=0;DP=271	GT	0/1
chr16	70515600	70515600	T	-	intronic	COG4	.	.	.	4.39E-06	0.997966814	0.002028798	DISEASE: Congenital disorder of glycosylation 2J (CDG2J) [MIM:613489]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N- glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:19494034}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26914	0.11324	-0.995664936	8.539749941	119.45307	2.37823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	199	chr16	70515599	chr16:70515599	GT	G	70	PASS	AN=2;DP=199	GT	0/1
chr16	75327731	75327731	-	A	UTR3	CFDP1	NM_006324:c.*118_*119insT	.	.	0.084939582	0.90532901	0.009731408	.	0.69235	0.12239	-0.115612493	45.12856806	45.52056	1.29597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	91	chr16	75327731	chr16:75327731	G	GA	62	PASS	AN=2;DP=91	GT	0/1
chr16	85146100	85146100	G	A	UTR5	FAM92B	NM_198491:c.-142C>T	.	.	3.59E-11	0.024359717	0.975640283	.	0.07343	0.09186	0.396906589	76.30927105	291.69998	3.65342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	245	chr16	85146100	chr16:85146100	G	A	61	PASS	AN=2;DP=245	GT	0/1
chr16	88105395	88105395	T	-	intronic	BANP	.	.	.	0.958647668	0.041348352	3.98E-06	.	0.64532	0.13415	-0.822919685	11.76574664	798.42168	5.56845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	104	chr16	88105394	chr16:88105394	CT	C	95	PASS	AN=2;DP=104	GT	0/1
chr17	3976075	3976075	C	G	intronic	ZZEF1	.	.	.	0.999923091	7.69E-05	6.61E-24	.	0.3881	0.10288	-3.376061946	0.389242746	5318.26057	15.07421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	50	chr17	3976075	chr17:3976075	C	G	61	PASS	AN=2;DP=50	GT	0/1
chr17	7363093	7363093	-	A	UTR3	ZBTB4	NM_020899:c.*2165_*2166insT;NM_001128833:c.*2165_*2166insT	.	.	0.998490203	0.001509768	2.89E-08	.	0.3783	0.08224	-0.10469683	45.64755839	312.5211	3.76241	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	257	chr17	7363093	chr17:7363093	G	GA	85	PASS	AN=2;DP=257	GT	0/1
chr17	18334142	18334142	T	G	ncRNA_intronic	KRT17P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	694	chr17	18334142	chr17:18334142	T	G	119	PASS	AN=2;DP=694	GT	0/1
chr17	30695056	30695056	C	T	intronic	ZNF207	.	.	.	0.054263846	0.944894719	0.000841434	.	0.55618	0.11352	-0.181750739	40.15687662	380.34086	4.1114	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	262	chr17	30695056	chr17:30695056	C	T	62	PASS	AN=2;DP=262	GT	0/1
chr17	30817689	30817689	-	A	UTR3	CDK5R1	NM_003885:c.*2127_*2128insA	.	.	0.738441122	0.250212258	0.011346619	.	0.54497	0.18399	-0.141298762	42.87567823	4.68969	0.1682	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	125	chr17	30817689	chr17:30817689	T	TA	69	PASS	AN=2;DP=125	GT	0/1
chr17	33998753	33998753	-	T	intronic	AP2B1	.	.	.	0.999667233	0.000332767	2.97E-11	.	0.71824	0.31324	-0.957024976	9.088228356	7.40151	0.27523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	150	chr17	33998753	chr17:33998753	C	CT	78	PASS	AN=2;DP=150	GT	0/1
chr17	35307623	35307623	G	A	exonic	AATF	.	synonymous SNV	AATF:NM_012138:exon2:c.G201A:p.T67T	1.62E-07	0.845766703	0.154233135	.	0.66679	0.29381	-0.286522835	33.47487615	319.73191	3.79794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	341	chr17	35307623	chr17:35307623	G	A	65	PASS	AN=2;DP=341	GT	0/1
chr17	36357125	36357144	AAATATATTTGAGCACTTAA	-	ncRNA_intronic	LOC440434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	303	chr17	36357124	chr17:36357124	TAAATATATTTGAGCACTTAA	T	78	PASS	AN=2;DP=303	GT	0/1
chr17	39974642	39974642	A	G	exonic	FKBP10	.	nonsynonymous SNV	FKBP10:NM_021939:exon4:c.A590G:p.K197R	0.000807425	0.983229411	0.015963164	DISEASE: Osteogenesis imperfecta 11 (OI11) [MIM:610968]: A form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI11 is an autosomal recessive form. {ECO:0000269|PubMed:20362275, ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bruck syndrome 1 (BRKS1) [MIM:259450]: A disease characterized by generalized osteopenia, congenital joint contractures, fragile bones with onset of fractures in infancy or early childhood, short stature, severe limb deformity, progressive scoliosis, and pterygia. {ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.44644	0.10813	-0.751322189	13.71196037	103.41854	2.19663	1.0	0.010	T	0.0	0.026	B	0.003	0.080	B	0.041	0.240	N	1	0.090	P	-1.85	0.003	N	0.82	0.481	T	1.41	0.008	N	0.036	0.016	-0.983	0.343	T	0.001	0.003	T	.	.	.	-2.128	0.006	0.001	0.143	0.003	0.204	0.208	N	c	-1.729	-1.528	0.971	0.292	0.722	0.854	0	1.37	0.211	3.252	0.509	-0.229	0.095	0.999	0.424	0.808	0.339	11.540	0.497	FKBP-type peptidyl-prolyl cis-trans isomerase domain	ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000259623.1|ENSG00000141698.12	Adipose_Subcutaneous|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Lung|Muscle_Skeletal|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Thyroid|Whole_Blood	0.5	182	153	chr17	39974642	chr17:39974642	A	G	182	PASS	AN=2;DP=153	GT	0/1
chr17	39976722	39976722	G	-	intronic	FKBP10	.	.	.	0.000807425	0.983229411	0.015963164	DISEASE: Osteogenesis imperfecta 11 (OI11) [MIM:610968]: A form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI11 is an autosomal recessive form. {ECO:0000269|PubMed:20362275, ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bruck syndrome 1 (BRKS1) [MIM:259450]: A disease characterized by generalized osteopenia, congenital joint contractures, fragile bones with onset of fractures in infancy or early childhood, short stature, severe limb deformity, progressive scoliosis, and pterygia. {ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.44644	0.10813	-0.751322189	13.71196037	103.41854	2.19663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	277	chr17	39976721	chr17:39976721	CG	C	76	PASS	AN=2;DP=277	GT	0/1
chr17	41102792	41102792	A	-	intronic	AARSD1;PTGES3L-AARSD1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	175	chr17	41102791	chr17:41102791	CA	C	71	PASS	AN=2;DP=175	GT	0/1
chr17	45664574	45664577	TTTT	-	intronic	NPEPPS	.	.	.	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.87	162	chr17	45664573	chr17:45664573	CTTTT	C,CTTTTT,CTTT	11.87	PASS	AN=0;DP=162	GT	0/1/.
chr17	45664577	45664577	-	T	intronic	NPEPPS	.	.	.	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.87	162	chr17	45664573	chr17:45664573	CTTTT	C,CTTTTT,CTTT	11.87	PASS	AN=0;DP=162	GT	0/1/.
chr17	45664577	45664577	T	-	intronic	NPEPPS	.	.	.	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.87	162	chr17	45664573	chr17:45664573	CTTTT	C,CTTTTT,CTTT	11.87	PASS	AN=0;DP=162	GT	0/1/.
chr17	46622002	46622002	G	-	exonic	HOXB2	.	frameshift deletion	HOXB2:NM_002145:exon1:c.272delC:p.P91Rfs*7	0.001838308	0.720699042	0.277462649	.	0.38232	.	-0.091746757	46.91554612	148.37143	2.65404	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	1002	chr17	46622001	chr17:46622001	CG	C	113	PASS	AN=2;DP=1002	GT	0/1
chr17	59857600	59857600	A	-	intronic	BRIP1	.	.	.	5.38E-13	0.932068251	0.067931749	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:11301010}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group J (FANCJ) [MIM:609054]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:16116423, ECO:0000269|PubMed:16116424, ECO:0000269|PubMed:20639400}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20765	0.27124	-0.637452658	16.73743808	155.97826	2.72998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	94	chr17	59857599	chr17:59857599	CA	C,CAA	67	PASS	AN=2;DP=94	GT	0/1
chr17	59857600	59857600	-	A	intronic	BRIP1	.	.	.	5.38E-13	0.932068251	0.067931749	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:11301010}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group J (FANCJ) [MIM:609054]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:16116423, ECO:0000269|PubMed:16116424, ECO:0000269|PubMed:20639400}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20765	0.27124	-0.637452658	16.73743808	155.97826	2.72998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	94	chr17	59857599	chr17:59857599	CA	C,CAA	67	PASS	AN=2;DP=94	GT	0/1
chr17	59974794	59974794	-	T	intronic	INTS2	.	.	.	0.999806217	0.000193783	3.25E-13	.	0.77276	0.13043	-0.620857637	17.3566879	100.80715	2.17423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.85	117	chr17	59974794	chr17:59974794	C	CT	12.85	PASS	AN=0;DP=117	GT	0/1
chr17	62852056	62852056	A	G	intronic	LRRC37A3	.	.	.	.	.	.	.	.	.	.	.	193.95095	3.02097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	195	chr17	62852056	chr17:62852056	A	G	.	PASS	AN=0;DP=195	GT	0/1
chr17	65720151	65720151	-	T	intronic	NOL11	.	.	.	0.027829353	0.972074352	9.63E-05	.	0.4979	0.07984	0.290313621	71.56758669	595.1741	4.93918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	173	chr17	65720150	chr17:65720150	CT	CTT,C	65	PASS	AN=2;DP=173	GT	0/1
chr17	65720151	65720151	T	-	intronic	NOL11	.	.	.	0.027829353	0.972074352	9.63E-05	.	0.4979	0.07984	0.290313621	71.56758669	595.1741	4.93918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	173	chr17	65720150	chr17:65720150	CT	CTT,C	65	PASS	AN=2;DP=173	GT	0/1
chr17	68175917	68175917	-	A	UTR3	KCNJ2	NM_000891:c.*3453_*3454insA	.	.	0.820229028	0.178898897	0.000872075	DISEASE: Long QT syndrome 7 (LQT7) [MIM:170390]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Long QT syndrome type 7 manifests itself as a clinical triad consisting of potassium-sensitive periodic paralysis, ventricular ectopy and dysmorphic features. {ECO:0000269|PubMed:11371347, ECO:0000269|PubMed:12148092, ECO:0000269|PubMed:12163457, ECO:0000269|PubMed:16571646, ECO:0000269|PubMed:17324964}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Short QT syndrome 3 (SQT3) [MIM:609622]: A heart disorder characterized by idiopathic persistently and uniformly short QT interval on ECG in the absence of structural heart disease in affected individuals. It causes syncope and sudden death. SQT3 has a unique ECG phenotype characterized by asymmetrical T waves. {ECO:0000269|PubMed:15761194}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atrial fibrillation, familial, 9 (ATFB9) [MIM:613980]: A familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure. {ECO:0000269|PubMed:15922306}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42866	0.22085	-0.582225231	18.44184949	8.98775	0.32999	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	288	chr17	68175917	chr17:68175917	G	GA	86	PASS	AN=2;DP=288	GT	0/1
chr17	73908392	73908392	A	-	intronic	FBF1	.	.	.	1.14E-19	0.008665209	0.991334791	.	0.10085	0.103	-0.694532205	14.83840528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	351	chr17	73908391	chr17:73908391	GA	G	71	PASS	AN=2;DP=351	GT	0/1
chr17	73967898	73967899	AC	-	intronic	ACOX1	.	.	.	0.094435306	0.905495422	6.93E-05	.	0.16046	0.77183	0.134171522	63.57041755	194.54546	3.02364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	300	chr17	73967897	chr17:73967897	AAC	A	61	PASS	AN=2;DP=300	GT	0/1
chr17	74017594	74017594	A	G	exonic	EVPL	.	synonymous SNV	EVPL:NM_001320747:exon9:c.T966C:p.C322C,EVPL:NM_001988:exon9:c.T966C:p.C322C	6.49E-14	0.99720216	0.00279784	.	0.45755	0.25979	0.769689266	86.89549422	2455.91155	9.22294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	151	chr17	74017594	chr17:74017594	A	G	.	PASS	AN=0;DP=151	GT	0/1
chr17	77809367	77809367	C	-	intronic	CBX4	.	.	.	0.381198482	0.608349045	0.010452473	.	0.87942	0.1035	0.106667882	61.73036093	1044.2776	6.20429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	623	chr17	77809366	chr17:77809366	AC	A	78	PASS	AN=2;DP=623	GT	0/1
chr18	13099601	13099601	-	T	intronic	CEP192	.	.	.	7.44E-10	0.999999897	1.02E-07	.	0.09044	0.10852	1.493675397	95.37037037	4911.21175	14.29193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	76	chr18	13099601	chr18:13099601	G	GT	92	PASS	AN=2;DP=76	GT	0/1
chr18	29522914	29522914	C	-	UTR5	TRAPPC8	NM_014939:c.-187delG	.	.	0.999999744	2.56E-07	1.56E-19	.	0.1499	0.09632	0.721954055	85.86341118	3775.56161	12.03543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	640	chr18	29522913	chr18:29522913	AC	A	82	PASS	AN=2;DP=640	GT	0/1
chr18	57013193	57013193	-	T	exonic	LMAN1	.	frameshift insertion	LMAN1:NM_005570:exon8:c.912dupA:p.E305Rfs*19	0.486069839	0.513889663	4.05E-05	DISEASE: Factor V and factor VIII combined deficiency 1 (F5F8D1) [MIM:227300]: A blood coagulation disorder characterized by bleeding symptoms similar to those in hemophilia or parahemophilia, that are caused by single deficiency of FV or FVIII, respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma levels of coagulation factors V and VIII are in the range of 5 to 30% of normal. {ECO:0000269|PubMed:10090935, ECO:0000269|PubMed:19787799}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1019	0.17526	-0.045835247	50.34206181	760.68404	5.46719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	359	chr18	57013193	chr18:57013193	C	CT	68	PASS	AN=2;DP=359	GT	0/1
chr19	757412	757412	A	G	exonic	MISP	.	nonsynonymous SNV	MISP:NM_173481:exon2:c.A466G:p.S156G	1.95E-10	0.034098173	0.965901827	.	0.13168	.	-0.031281682	50.5779665	693.62656	5.25135	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.904	0.086	N	1	0.090	P	-0.82	0.015	N	0.75	0.502	T	0.42	0.034	N	0.015	0.002	-0.951	0.408	T	0.000	0.000	T	.	.	.	-1.729	0.012	0.002	0.144	0.003	0.019	0.058	N	c	-1.589	-1.521	0.002	0.092	0.581	0.326	0	-0.862	0.101	-1.156	0.032	-0.535	0.048	0.000	0.063	0.675	0.304	5.825	0.177	.	.	.	0.5	139	89	chr19	757412	chr19:757412	A	G	139	PASS	AN=2;DP=89	GT	0/1
chr19	1371193	1371193	C	A	intronic	MUM1	.	.	.	0.032092633	0.967523954	0.000383414	.	0.0715	0.13329	-0.661316159	16.02382637	285.13749	3.61395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	169	358	chr19	1371193	chr19:1371193	C	A	169	PASS	AN=2;DP=358	GT	0/1
chr19	2038031	2038031	C	-	UTR3	MKNK2	NM_199054:c.*1581delG	.	.	9.34E-06	0.777281387	0.222709276	.	0.18067	0.14759	-0.576764155	18.7839113	742.98614	5.41125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	354	chr19	2038030	chr19:2038030	AC	A	60	PASS	AN=2;DP=354	GT	0/1
chr19	2401897	2401897	C	T	intronic	TMPRSS9	.	.	.	1.77E-18	0.011731011	0.988268989	.	0.07122	.	1.646179058	96.19013918	6013.59996	16.19227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	116	chr19	2401897	chr19:2401897	C	T	54	PASS	AN=2;DP=116	GT	0/1
chr19	3834740	3834740	G	A	ncRNA_intronic	MIR1268A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	196	chr19	3834740	chr19:3834740	G	A	121	PASS	AN=2;DP=196	GT	0/1
chr19	4294807	4294807	G	A	exonic	TMIGD2	.	nonsynonymous SNV	TMIGD2:NM_001308232:exon2:c.C53T:p.P18L,TMIGD2:NM_001169126:exon3:c.C413T:p.P138L,TMIGD2:NM_144615:exon3:c.C413T:p.P138L	0.01525187	0.878338597	0.106409533	.	0.08093	.	1.931026376	97.46992215	710.71198	5.29848	0.118	0.281	T	0.032	0.189	B	0.015	0.162	B	.	.	.	1	0.090	P	0.345	0.112	N	1.62	0.317	T	-2.87	0.603	D	0.021	0.005	-0.996	0.309	T	0.000	0.000	T	.	.	.	-0.525	0.054	0.191	0.781	0.117	0.008	0.032	N	c	-1.298	-1.427	0.000	0.042	0.516	0.203	0	-4.98	0.028	-0.450	0.068	-0.094	0.117	0.000	0.063	0.022	0.137	0.988	0.013	.	.	.	0.5	124	58	chr19	4294807	chr19:4294807	G	A	124	PASS	AN=2;DP=58	GT	0/1
chr19	4502145	4502145	-	T	UTR3	HDGFL2	NM_032631:c.*123_*124insT;NM_001001520:c.*123_*124insT;NM_001348169:c.*123_*124insT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	172	chr19	4502145	chr19:4502145	G	GT	74	PASS	AN=2;DP=172	GT	0/1
chr19	4510389	4510389	C	-	intronic	PLIN4	.	.	.	1.66E-12	0.007710433	0.992289567	.	0.16259	0.102	5.994578529	99.85845718	9818.87991	21.57786	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	15.22	142	chr19	4510388	chr19:4510388	AC	A	15.22	PASS	AN=0;DP=142	GT	0/1
chr19	6414075	6414075	-	A	UTR3	KHSRP	NM_003685:c.*47_*48insT	.	.	0.999711222	0.000288778	5.13E-10	.	0.45176	0.15486	-0.690637458	15.12149092	19.12445	0.65912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	250	chr19	6414075	chr19:6414075	G	GA	68	PASS	AN=2;DP=250	GT	0/1
chr19	7529415	7529415	C	T	intronic	ARHGEF18	.	.	.	0.908367516	0.091632236	2.47E-07	.	0.10895	0.10442	0.655813101	84.18848785	444.31169	4.38418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	112	chr19	7529415	chr19:7529415	C	T	135	PASS	AN=2;DP=112	GT	0/1
chr19	9003565	9003565	C	A	splicing	MUC16	NM_024690:exon49:c.40074+1G>T	.	.	.	.	.	.	0.05884	.	29.75317221	100	23894.83454	31.77381	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2.826	0.400	21.5	0.962	0.284	0.914	0.533	D	c	0.666	0.383	0.008	0.116	0.061	0.009	0	3.24	0.361	3.457	0.525	0.764	0.310	0.991	0.370	0.016	0.126	10.646	0.446	.	.	.	0.5	115	153	chr19	9003565	chr19:9003565	C	A	115	PASS	AN=2;DP=153	GT	0/1
chr19	13941567	13941567	C	T	exonic	ZSWIM4	.	synonymous SNV	ZSWIM4:NM_023072:exon13:c.C2673T:p.P891P	0.165803304	0.834071799	0.000124897	.	0.24652	.	-1.322782544	4.759377212	1113.90385	6.3763	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	606	chr19	13941567	chr19:13941567	C	T	74	PASS	AN=2;DP=606	GT	0/1
chr19	16222677	16222677	G	T	UTR5	RAB8A	NM_005370:c.-35G>T	.	.	0.962128955	0.037793365	7.77E-05	.	0.20304	0.31462	-0.251530012	35.42108988	1.07555	0.02762	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	201	933	chr19	16222677	chr19:16222677	G	T	201	PASS	AN=2;DP=933	GT	0/1
chr19	33490500	33490500	C	T	exonic	RHPN2	.	nonsynonymous SNV	RHPN2:NM_033103:exon10:c.G1217A:p.R406Q	0.000336631	0.997287291	0.002376078	.	0.1907	0.10228	0.003714825	54.06935598	5254.99892	14.95444	0.33	0.131	T	0.046	0.205	B	0.011	0.145	B	0.546	0.053	N	1	0.090	N	0.72	0.188	N	1.92	0.231	T	-1.58	0.381	N	0.045	0.025	-1.048	0.150	T	0.066	0.274	T	0.014	0.345	T	2.284	0.336	18.06	0.984	0.411	0.008	0.031	N	c	-1.114	-1.210	1.000	0.425	0.672	0.522	0	-6.97	0.015	-0.603	0.057	-0.079	0.119	0.000	0.063	0.088	0.184	3.396	0.068	BRO1 domain	.	.	0.5	98	174	chr19	33490500	chr19:33490500	C	T	98	PASS	AN=2;DP=174	GT	0/1
chr19	36821265	36821265	-	T	ncRNA_exonic	LINC00665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	824	chr19	36821265	chr19:36821265	A	AT	95	PASS	AN=2;DP=824	GT	0/1
chr19	41533087	41533087	T	C	intergenic	CYP2B6;CYP2A13	dist=8786;dist=61269	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	367	chr19	41533087	chr19:41533087	T	C	128	PASS	AN=2;DP=367	GT	0/1
chr19	44098881	44098881	G	-	intronic	IRGQ	.	.	.	0.001197228	0.956861915	0.041940857	.	0.11132	0.10002	0.174625237	65.9648502	46.00143	1.30616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	202	505	chr19	44098880	chr19:44098880	AG	A	202	PASS	AN=2;DP=505	GT	0/1
chr19	44768383	44768383	A	G	intronic	ZNF233	.	.	.	3.27E-17	0.000346158	0.999653842	.	0.09894	.	0.97558591	90.37508846	4670.83871	13.76453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	157	chr19	44768383	chr19:44768383	A	G	45	PASS	AN=2;DP=157	GT	0/1
chr19	46124695	46124695	G	-	intronic	EML2	.	.	.	7.58E-10	0.671944659	0.32805534	.	0.17207	0.11401	0.224175308	68.48903043	3227.53207	10.82078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	476	chr19	46124694	chr19:46124694	CG	C	84	PASS	AN=2;DP=476	GT	0/1
chr19	48229340	48229340	G	A	exonic	EHD2	.	stopgain	EHD2:NM_014601:exon4:c.G774A:p.W258X	0.531641412	0.464989568	0.00336902	.	0.14909	0.13604	-1.041578376	7.773059684	254.81204	3.43303	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.895	0.979	38	0.997	0.796	0.974	0.741	D	c	0.831	0.661	1.0	0.983	0.672	0.522	0	3.66	0.409	9.801	0.982	0.939	0.529	1.000	0.715	0.985	0.512	13.284	0.595	Dynamin-type guanine nucleotide-binding (G) domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	128	406	chr19	48229340	chr19:48229340	G	A	128	PASS	AN=2;DP=406	GT	0/1
chr19	49606750	49606750	C	-	intronic	SNRNP70	.	.	.	0.993095086	0.006904675	2.39E-07	.	0.54826	0.24974	.	.	34.51837	1.05414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	684	chr19	49606749	chr19:49606749	TC	T	129	PASS	AN=2;DP=684	GT	0/1
chr19	49982166	49982166	C	-	exonic	FLT3LG	.	frameshift deletion	FLT3LG:NM_001204503:exon5:c.343delC:p.S118Afs*23,FLT3LG:NM_001204502:exon6:c.343delC:p.S118Afs*23,FLT3LG:NM_001278637:exon6:c.97delC:p.S36Afs*23,FLT3LG:NM_001278638:exon6:c.97delC:p.S36Afs*23,FLT3LG:NM_001459:exon6:c.343delC:p.S118Afs*23	0.950828698	0.049022409	0.000148893	.	0.24328	0.14299	-0.560178693	19.30879925	10.2966	0.3755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	484	chr19	49982165	chr19:49982165	GC	G	86	PASS	AN=2;DP=484	GT	0/1
chr19	52380575	52380575	T	C	exonic	ZNF577	.	synonymous SNV	ZNF577:NM_001135590:exon6:c.A243G:p.P81P,ZNF577:NM_032679:exon6:c.A243G:p.P81P	0.012941322	0.953743723	0.033314955	.	0.10716	.	1.489991751	95.35857514	3127.20421	10.63952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	96	chr19	52380575	chr19:52380575	T	C	.	PASS	AN=0;DP=96	GT	0/1
chr19	53643736	53643736	C	G	exonic	ZNF347	.	nonsynonymous SNV	ZNF347:NM_001172674:exon5:c.G2348C:p.R783T,ZNF347:NM_001172675:exon5:c.G2348C:p.R783T,ZNF347:NM_032584:exon5:c.G2345C:p.R782T	1.26E-17	0.000733205	0.999266795	.	0.06109	.	-0.551080959	19.93394669	53.4466	1.45289	0.766	0.035	T	0.0	0.026	B	0.001	0.040	B	.	.	.	1	0.090	N	1.25	0.319	L	1.75	0.262	T	-0.46	0.150	N	0.161	0.193	-0.975	0.362	T	0.025	0.109	T	0.001	0.013	T	-1.541	0.016	0.002	0.101	0.001	0.003	0.017	N	c	-2.158	-2.276	0.067	0.154	0.635	0.413	0	-4.58	0.032	-5.699	0.001	-1.831	0.006	0.000	0.063	0.000	0.016	0.457	0.005	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	105	188	chr19	53643736	chr19:53643736	C	G	105	PASS	AN=2;DP=188	GT	0/1
chr19	53644952	53644952	C	G	exonic	ZNF347	.	nonsynonymous SNV	ZNF347:NM_001172674:exon5:c.G1132C:p.E378Q,ZNF347:NM_001172675:exon5:c.G1132C:p.E378Q,ZNF347:NM_032584:exon5:c.G1129C:p.E377Q	1.26E-17	0.000733205	0.999266795	.	0.06109	.	-0.551080959	19.93394669	53.4466	1.45289	0.087	0.324	T	0.843	0.446	P	0.397	0.426	B	.	.	.	1	0.090	N	0.585	0.154	N	3.19	0.074	T	-2.38	0.524	N	0.101	0.104	-0.963	0.386	T	0.012	0.048	T	0.002	0.039	T	0.270	0.120	5.403	0.989	0.478	0.044	0.099	N	c	-0.870	-0.970	0.000	0.038	0.563	0.310	0	0.361	0.153	-0.603	0.057	0.552	0.283	0.000	0.063	0.128	0.199	5.721	0.171	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	136	167	chr19	53644952	chr19:53644952	C	G	136	PASS	AN=2;DP=167	GT	0/1
chr19	54721260	54721260	G	A	exonic	LILRB3	.	synonymous SNV	LILRB3:NM_001081450:exon12:c.C1680T:p.P560P,LILRB3:NM_006864:exon12:c.C1677T:p.P559P,LILRB3:NM_001320960:exon13:c.C1728T:p.P576P	0.027760685	0.969891931	0.002347384	.	0.07088	.	1.756425229	96.70912951	1162.94093	6.49058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	190	chr19	54721260	chr19:54721260	G	A	86	PASS	AN=2;DP=190	GT	0/1
chr19	55795425	55795425	G	A	upstream	BRSK1	dist=109	.	.	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	1124	chr19	55795425	chr19:55795425	G	A	88	PASS	AN=2;DP=1124	GT	0/1
chr19	55815036	55815036	C	-	exonic	BRSK1	.	frameshift deletion	BRSK1:NM_032430:exon12:c.1128delC:p.R379Gfs*8	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	580	chr19	55815035	chr19:55815035	AC	A	111	PASS	AN=2;DP=580	GT	0/1
chr20	7976721	7976721	-	A	intronic	TMX4	.	.	.	0.010662181	0.946183863	0.043153956	.	0.16188	.	-0.0274281	51.65723048	79.9201	1.88959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	221	chr20	7976721	chr20:7976721	T	TA	75	PASS	AN=2;DP=221	GT	0/1
chr20	29589699	29589699	G	A	intergenic	LINC01598;FRG1BP	dist=19336;dist=22141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	207	chr20	29589699	chr20:29589699	G	A	105	PASS	AN=2;DP=207	GT	0/1
chr20	32664877	32664877	C	T	exonic	RALY	.	synonymous SNV	RALY:NM_007367:exon7:c.C654T:p.G218G,RALY:NM_016732:exon8:c.C702T:p.G234G	0.55457384	0.442614262	0.002811898	.	0.18001	0.13451	-0.093566408	46.7386176	666.56385	5.16662	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	328	chr20	32664877	chr20:32664877	C	T	75	PASS	AN=2;DP=328	GT	0/1
chr20	33665776	33665776	-	A	intronic	TRPC4AP	.	.	.	0.999538656	0.000461344	1.33E-11	.	0.44984	0.11627	-1.263883952	5.260674687	88.3574	2.01455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	301	chr20	33665775	chr20:33665775	GA	GAA,G	111	PASS	AN=2;DP=301	GT	0/1
chr20	33665776	33665776	A	-	intronic	TRPC4AP	.	.	.	0.999538656	0.000461344	1.33E-11	.	0.44984	0.11627	-1.263883952	5.260674687	88.3574	2.01455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	301	chr20	33665775	chr20:33665775	GA	GAA,G	111	PASS	AN=2;DP=301	GT	0/1
chr20	37216665	37216665	A	G	intronic	ADIG	.	.	.	.	.	.	.	0.22628	.	0.080983847	59.76055674	11.12436	0.40271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	209	chr20	37216665	chr20:37216665	A	G	60	PASS	AN=2;DP=209	GT	0/1
chr20	42281780	42281780	C	T	intergenic	IFT52;MYBL2	dist=5844;dist=13879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	214	chr20	42281780	chr20:42281780	C	T	64	PASS	AN=2;DP=214	GT	0/1
chr20	51588866	51588868	GAG	-	upstream	TSHZ2	dist=78	.	.	0.406843773	0.5927903	0.000365927	.	0.13647	0.11806	-0.916836882	9.831328143	361.35552	4.02303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	189	chr20	51588865	chr20:51588865	AGAG	A	113	PASS	AN=2;DP=189	GT	0/1
chr21	33993852	33993852	-	T	intergenic	C21orf59-TCP10L;SYNJ1	dist=8671;dist=7217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	294	chr21	33993852	chr21:33993852	C	CT	71	PASS	AN=2;DP=294	GT	0/1
chr21	38132055	38132055	T	C	exonic	HLCS	.	nonsynonymous SNV	HLCS:NM_000411:exon10:c.A1768G:p.M590V,HLCS:NM_001242784:exon10:c.A1768G:p.M590V,HLCS:NM_001242785:exon10:c.A1768G:p.M590V	0.486548324	0.513252415	0.000199261	.	0.07149	0.25106	-0.591542347	18.24722812	151.46286	2.69061	0.348	0.124	T	0.002	0.090	B	0.007	0.121	B	0.112	0.194	N	1.000	0.192	N	0.735	0.189	N	-3.32	0.939	D	-1.09	0.283	N	0.178	0.218	-0.471	0.697	T	0.400	0.751	T	0.042	0.603	D	0.448	0.137	7.021	0.640	0.072	0.097	0.152	N	c	-1.260	-1.285	1.000	0.747	0.638	0.428	0	-8.42	0.008	0.029	0.134	0.008	0.138	0.007	0.175	0.987	0.523	2.446	0.042	Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL), catalytic domain	.	.	0.5	.	77	chr21	38132055	chr21:38132055	T	C	.	PASS	AN=0;DP=77	GT	0/1
chr22	32650200	32650200	C	T	exonic	SLC5A4	.	nonsynonymous SNV	SLC5A4:NM_014227:exon2:c.G136A:p.A46T	2.60E-13	0.125757351	0.874242649	.	0.08441	0.1124	0.736704836	86.32932295	914.47301	5.88119	0.017	0.512	D	0.228	0.288	B	0.206	0.354	B	0.000	0.843	D	0.000	0.588	P	2.89	0.840	M	-2.33	0.879	D	-1.68	0.401	N	0.167	0.207	-0.909	0.470	T	0.003	0.009	T	.	.	.	4.996	0.672	25.1	0.995	0.702	0.940	0.597	D	c	-0.113	-0.109	0.000	0.064	0.554	0.246	0	3.19	0.356	0.590	0.235	0.038	0.153	0.998	0.411	0.133	0.200	12.082	0.528	.	.	.	0.5	114	50	chr22	32650200	chr22:32650200	C	T	114	PASS	AN=2;DP=50	GT	0/1
chr22	32756652	32756652	A	G	exonic	RFPL3	.	nonsynonymous SNV	RFPL3:NM_001098535:exon2:c.A787G:p.S263G,RFPL3:NM_006604:exon3:c.A700G:p.S234G	0.000158443	0.437571789	0.562269768	.	0.04317	.	0.687150476	85.17928757	1089.79284	6.32074	0.219	0.190	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	0.935	0.237	L	0.12	0.611	T	-0.28	0.116	N	0.056	0.078	-1.028	0.211	T	0.108	0.392	T	.	.	.	-1.537	0.016	0.002	0.517	0.045	0.000	0.002	N	c	-1.461	-1.545	0.003	0.100	0.549	0.223	0	0.115	0.139	-0.551	0.061	-1.073	0.019	0.000	0.063	0.004	0.083	6.122	0.193	B30.2/SPRY domain|Concanavalin A-like lectin/glucanase domain|SPRY domain	.	.	0.5	110	390	chr22	32756652	chr22:32756652	A	G	110	PASS	AN=2;DP=390	GT	0/1
chr22	35719556	35719556	G	A	exonic	TOM1	.	nonsynonymous SNV	TOM1:NM_001135729:exon5:c.G335A:p.R112Q,TOM1:NM_001135732:exon5:c.G434A:p.R145Q,TOM1:NM_005488:exon5:c.G434A:p.R145Q	6.78E-06	0.974913137	0.025080085	.	0.25337	0.13124	-0.554717505	19.79830149	1589.92055	7.37684	0.007	0.599	D	1.0	0.899	D	0.962	0.708	D	0.000	0.843	D	1.000	0.810	D	1.435	0.361	L	1.97	0.221	T	-2.48	0.567	N	0.31	0.576	-1.037	0.181	T	0.104	0.381	T	0.032	0.538	D	6.875	0.930	33	0.999	0.978	0.922	0.548	D	c	0.454	0.461	1.000	0.446	0.732	0.924	0	4.74	0.596	3.962	0.562	0.953	0.551	1.000	0.715	0.998	0.697	17.725	0.882	ENTH/VHS|VHS domain|VHS subgroup	.	.	0.5	64	255	chr22	35719556	chr22:35719556	G	A	64	PASS	AN=2;DP=255	GT	0/1
chr22	38380439	38380439	C	T	UTR5	SOX10	NM_006941:c.-648G>A	.	.	0.913097851	0.086276806	0.000625343	DISEASE: Waardenburg syndrome 4C (WS4C) [MIM:613266]: A disorder characterized by the association of Waardenburg features (depigmentation and deafness) with the absence of enteric ganglia in the distal part of the intestine (Hirschsprung disease). {ECO:0000269|PubMed:18348274, ECO:0000269|PubMed:21898658, ECO:0000269|PubMed:9462749}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136]: A complex neurocristopathy that includes features of 4 distinct syndromes: peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease. {ECO:0000269|PubMed:10762540, ECO:0000269|PubMed:15004559, ECO:0000269|PubMed:19208381, ECO:0000269|PubMed:21898658}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.98629	0.45051	-0.471992905	23.03609342	24.56042	0.80765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	454	chr22	38380439	chr22:38380439	C	T	.	PASS	AN=0;DP=454	GT	0/1
chr22	49147663	49147663	-	T	UTR3	FAM19A5	NM_001082967:c.*2004_*2005insT;NM_015381:c.*2004_*2005insT	.	.	0.310031382	0.617806909	0.07216171	.	0.13152	.	0.347360312	73.97381458	13.36073	0.48609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	409	chr22	49147663	chr22:49147663	A	AT	92	PASS	AN=2;DP=409	GT	0/1
chrX	53113896	53113896	G	-	intronic	TSPYL2	.	.	.	0.874635828	0.125031878	0.000332294	.	0.13703	0.27669	-0.712684326	14.49634348	93.79731	2.08252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	108	chrX	53113895	chrX:53113895	TG	T	69	PASS	AN=2;DP=108	GT	0/1
chrX	57620213	57620213	C	G	exonic	ZXDB	.	nonsynonymous SNV	ZXDB:NM_007157:exon1:c.C1732G:p.L578V	0.842955569	0.154160523	0.002883908	.	0.06264	0.09943	.	.	96.86419	2.12723	0.126	0.272	T	0.997	0.689	D	0.978	0.725	D	0.000	0.481	D	0.950	0.377	D	2.73	0.801	M	3.01	0.091	T	-1.43	0.352	N	0.35	0.411	-1.122	0.022	T	0.048	0.205	T	0.020	0.426	T	0.986	0.188	10.58	0.978	0.353	0.940	0.595	D	.	.	.	1.000	0.747	.	.	.	2.96	0.332	3.684	0.542	0.887	0.390	1.000	0.715	0.997	0.653	8.628	0.329	.	.	.	0.5	126	193	chrX	57620213	chrX:57620213	C	G	126	PASS	AN=2;DP=193	GT	0/1
